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ABSTRACT
DIL - A Conversational Agent for Heart Failure Patients
By
Sanjoy Moulik
Claremont Graduate University: 2019

There is an exceptionally high rate of readmissions and rehospitalizations for patients suffering from chronic diseases especially
Heart Failure. Best efforts to address this alarming problem from the Care giver community have fallen short due to a number of
factors most notably resource constraints like shortage of trained clinical staff, and money. Using a Design Science Research
framework, this work designed and evaluated "DIL", a Conversational Agent that complements the work of clinicians in
achieving the desired behavioral and clinical outcomes. The aim is to provide the hospital with an information system that could
bridge the current gap in care that occurs when the patient transitions from the hospital environment to the home environment.

The expected contribution is to produce a novel artifact and demonstrate the efficacy and utility of the tool to assist patients with
heart failure in improving their self-care. The study conclusions were extremely positive. DIL scored high on User engagement
and satisfaction. Every patient felt significantly more positive after their interaction with DIL during the trial period, and had a
positive outlook on their quality of life going forward. The patients in the trial found DIL to be helpful in keeping them motivated
to follow a healthy lifestyle by controlling their diet, and adhering to clinical guidelines of regular exercise, and taking
medications on a timely manner. Given the extremely positive experience of the patients, there is definitely room for such an IT
artifact in supporting patients as they make the transition from hospital to the home setting.
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CHAPTER 1: INTRODUCTION
1.1 M O T I VA T I O N
Chronic conditions are increasingly impacting life expectancy and the cost of healthcare all over the world. Among these
conditions, Cardiovascular Disease (CVD) stands out because its prevalence continues to rise. According to American Heart
Association, Heart Disease and Stroke Statistics 2018 [1], the numbers are alarming:

• Cardiovascular disease, listed as the underlying cause of death, accounts for nearly 836,546 deaths in the US. That’s about 1 of
every 3 deaths in the US. About 2,300 Americans die of cardiovascular disease each day, an average of 1 death every 38
seconds. Cardiovascular diseases claim more lives each year than all forms of cancer and Chronic Lower Respiratory Disease
combined. Coronary Heart Disease is the leading cause (43.8 percent) of deaths attributable to cardiovascular disease in the US,
followed by Stroke (16.8 percent), Heart Failure (9.0 percent), High Blood Pressure (9.4 percent), diseases of the arteries (3.1
percent), and other cardiovascular diseases (17.9 percent).
• Heart Disease (including Coronary Heart Disease, Hypertension, and Stroke) remains the No. 1 cause of death in the US.
Coronary heart disease accounts for 1 in 7 deaths in the US, killing over 366,800 people a year. The overall prevalence for MI
in the US is about 7.9 million, or 3 percent, in US adults. In 2015, heart attacks claimed 114,023 lives in the US.
• Cardiovascular disease is the leading global cause of death, accounting for more than 17.9 million deaths per year in 2015, a
number that is expected to grow to more than 23.6 million by 2030.
• Nearly half of all NH black adults have some form of cardiovascular disease, 47.7 percent of females and 46.0 percent of
males.
• The estimated annual incidence of heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. Average age at
the first heart attack is 65.6 years for males and 72.0 years for females. Approximately every 40 seconds, an American will
have a heart attack.
• From 2005 to 2015, the annual death rate attributable to coronary heart disease declined 34.4 percent and the actual number of
deaths declined 17.7% – but the burden and risk factors remain alarmingly high.
• About 92.1 million American adults are living with some form of cardiovascular disease or the after-effects of stroke. Direct
and indirect costs of total cardiovascular diseases and stroke are estimated to total more than $329.7 billion; that includes both
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health expenditures and lost productivity. CVD and stroke accounted for 14% of total health expenditures in 2013-2014. This is
more than any major diagnostic group. Total direct medical costs of CVD are projected to increase to $749 billion in 2035.
• The estimated direct and indirect cost of heart disease in 2013 to 2014 (average annual) was $204.8 billion. Heart attacks
($12.1 billion) and Coronary Heart Disease ($9.0 billion) were 2 of the 10 most expensive conditions treated in US hospitals in
2013. Between 2013 and 2030, medical costs of Coronary Heart Disease are projected to increase by about 100 percent.

In 2012, the American Heart Association reported that 1 out of 5 of individuals with heart failure dies within a year of diagnosis
[2]. Although CVD is not curable, evidence shows that the quality of life and life expectancy of individuals with heart failure
could be improved if the condition is managed by adhering to medications, monitoring symptoms, and salt intake, etc. [3].
Hospital readmissions remain a continued challenge in the care of the heart failure patient. Although small gains have been made
over the past 5 years, still more than 20% of patients are readmitted within 30 days and up to 50% by 6 months [57]. The cost of
these readmissions exceeded $15 billion per year for Congestive Heart Failure (CHF) patients (MedCAP) [1]. As readmissions
continued, the Center for Medicare and Medicaid Services (CMS) decided to penalize hospitals with high heart failure
readmission rates by not reimbursing them for the services they provide since prior studies show that heart failure hospital
readmissions could be reduced with quality outpatient services and adherence to care.

CHF is common in the elderly population. As such, the increasing number of cases could be correlated with the aging population.
About 10 in 1000 individuals over the age of 65 have CHF and 80% of CHF related hospitalizations are for patients over 65 [4].

Yet, the high readmission rates for heart failure cases have also been attributed to the lack of effective strategies to support the
transition in care from the hospital to the home environment. Individuals with heart failure are discharged with the need to
manage their comorbidities, physical limitations, personal struggles, lack of information, difficulties adapting with treatments,
and debilitating symptoms [5,6]. With proper disease management, early symptoms of disease exacerbation could be detected and
treatments could be initiated to prevent them [3], lowering the risk of deteriorating quality of life, death, or readmission to the
hospital. Therefore, the American Heart Association recommends patient education and close monitoring to improve treatment
adherence [6].

Hospitals vary in the strategies they implement to reduce readmissions. Studies have shown that employing heart failure
programs and nurse-directed interventions help [7]. Yet, more evidence is needed for effective strategies to reduce readmissions
because the limited number of clinicians can not address the growing needs of patients.
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HOME MONITORING SYSTEM
Nagla Alnosayan of the IDEA Lab at the Claremont Graduate University - Center for Information Systems and Technology
(CISAT), developed a "Home Telemonitoring System" to support self-care in the context of Congestive Heart Failure Patients, as
part of her PhD dissertation [32]. The system was designed, developed and evaluated for the heart failure rehabilitation center at
Loma Linda University Medical Center. The project tried to address the current gap in care that occurs when the patient
transitions from the hospital environment to the home environment. The research project had lots of interesting findings, but what
really stood out and is relevant to this study is the fact that Human support cannot scale, and is constrained by a number of
factors, and the patients continue to remain socially isolated especially in the poorer sections of the society. Even though data
was remotely collected from homes, and the system could automatically classify the risks of patients, human health workers were
needed to intervene and talk to patients for guidance.

This expert rule-based Home monitoring system provides the background, and motivation for the current research to develop an
automated intervention system that can be triggered based on patient's risk profile; a software artifact we call DIL that will aim to
address the two specific findings of interest – scalability of Human support, and social isolation.

1. 2 P RO B L E M S TAT E M E N T
Data shows that there is an extremely high number of readmissions (rehospitalizations) for Heart Failure patients particularly
CHF cases [8,9]. The costs incurred to treat these cases is skyrocketing. So, there is a tremendous need for effective approaches
to manage CHF in such a way that deteriorating cases could be detected and treated before they require hospitalization and more
specifically rehospitalization. Different strategies like nurse interventions have been tried out, and met with some success, but in
practice their implementation remains low, and many patients do not receive self-care support once they are discharged.

More specifically, the following problems come to the fore when we take a deeper look at these patients:

•

They Forget — There is a need to send them reminders to take their prescribed medications, and adhere to the
recommended behavior changes like exercise and diet.

•

They Need Assistance — In many cases they need help and guidance to follow the recommended behavior changes.

•

Social Connection — Many of these patients especially in the under privileged sections of the society are socially
isolated.

•

Social Motivation — Many have simply given up on the fight and lack the motivation to get better.

•

Human support and Scale –– In an extremely constrained environment, human support cannot scale.

3

This was evident at an interview with the director of cardiovascular wellness at Loma Linda University. The challenge with
implementing such interventions could be related to the limited number of clinicians and the growing number of patients.
Therefore, there is a need to identify strategies that have the potential to identify patients at risk and target clinical resources
towards them; in particular some novel ICT-enabled strategies could be very beneficial.

It will also be interesting to find out why the patients fail to adhere to clinical guidelines, what factors prevent them from doing
the needful, so that the nurses, doctors and other Health workers can create tailored treatment plans to achieve the desired health
outcomes.

Existing health literature articulates the need for research pertaining to CHF self-care promotion. This creates a gap in the
literature that this research intends to fill.

1. 3 P U R P O S E O F T H E S T U DY
As mentioned in previous sections, the cost of managing chronic conditions like heart failure is significant, and is a tremendous
burden to the society at large. Hospitals are often penalized when patients are readmitted within a short duration but despite best
efforts, the caregiver community routinely struggle to meet the needs of a huge and diverse patient population. Health
professionals have limited resources and are not able to personally monitor and support patients in their everyday life. Human
support simply cannot scale to cope with an ever-growing aging population suffering from CVDs. There also seems to be a lack
of effective strategies to support the transition in care from the hospital to the home environment.

In this scenario, self care and self management of these conditions becomes even more critical. A technology solution that can aid
in the process of self monitoring of vital health data, and provide timely interventions like reminders and motivations for the
patients to follow clinical guidelines can go a long way to ease the caregiver burden. Previous studies with Conversational Agents
or Chatbots have shown positive outcomes in self-efficacy and attitude change [24].

The purpose of this study is to evaluate the artifact, DIL, a conversational agent for heart-failure patients. Can DIL elicit behavior
change, and better adherence to clinical guidelines for the patients in the study group will be a driving question for this research
because if it can, then we can safely say that there is definitely room for an IT artifact to address the gap in continuing care as
patients transition to home setting as human support can scale. The researcher seeks to compare the patients' behavior and health
outcomes, before and during intervention by employing quantitative and qualitative instruments.
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C HAPTER 2: LITERATURE REVIEW
2 .1 B A C K G R O U N D
CONGESTIVE HEART FAILURE
Congestive Heart Failure (CHF) is a condition that occurs when the heart fails to pump enough blood and oxygen to other organs.
Common causes for heart failure include coronary artery disease, high blood pressure, and diabetes [2]. The severity of the
disease is often classified into four categories as per the New York Heart Association (NYHA) functional classification These
categories are based on the individual’s limitations during physical activity and are described in the following table.

Table 1: NYHA Functional Classification
NYHA CLASS

SYMPTOMS

I

Cardiac disease, but no symptoms and no limitation in ordinary physical
activity, e.g. shortness of breath when walking, climbing stairs, etc.

II

Mild symptoms (mild shortness of breath and/or angina) and slight
limitation during ordinary activity.

III

Marked limitation in activity due to symptoms, even during less than
ordinary activity, e.g. walking short distances (20–100 m). Comfortable
only at rest.

IV

Severe limitations. Experiences symptoms even while at rest. Mostly
bedbound patients.

Table 1: NYHA Functional Classification
As a chronic condition, CHF could be managed with adhering to medications, following a low salt diet, exercising and
measuring, recording, and observing vitals and symptoms such as:

•

Weight

•

Abnormal blood pressure

•

Blood glucose levels out of target range if the individual has diabetes

•

Shortness of breath

•

Swelling

•

Chest pain, etc.
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Depending on the severity of symptoms, heart failure patients may need to get support or immediate evaluation from the clinical
care team to adjust medications (e.g., diuretics) and/or change diet (e.g., restrict sodium intake) to control symptoms.

The process of monitoring symptoms to evaluate treatment is modeled as a 5-stage process that goes from monitoring to
recognizing symptoms (e.g., new swelling) and from implementing treatment (e.g., take an extra diuretic dose) to evaluating it as
shown in Figure 1 [6].

Figure 1: Self-Care of Heart Failure Model (Source: Reigel et al., 2008)
When patients are discharged, they often receive written and verbal instructions to promote self-care but they typically do not
understand them since self-care is dependent on the individual’s educational level, age, gender, social support, self confidence,
self-perceived health, and self-efficacy [6]. In addition, several barriers to self-care exist such as: physical limitations, debilitating
symptoms, difficulties coping with treatment, lack of knowledge, distressed emotions, multiple comorbidities, and personal
struggles [5].

Supervising patients after discharge provides an opportunity to identify cases at risk. Therefore, the American Heart Association
recommends patient education and close supervision [1]. Education topics include symptoms, weight, dietary (i.e., a sodium
restricted diet), medications, and exercise [11,12]. When CHF disease management programs are implemented, functional status
and quality of life improve while hospital readmissions due to exacerbations decrease (7,10].

With the rapidly increasing number of CHF cases and the scarcity of clinical resources services, risk stratification is key in CHF
management in order to target healthcare services at individuals who need them the most and are likely to benefit from them.
While risk stratification models such as the Seattle Heart Failure Model [13] exist, they require laboratory parameters and are not
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suitable for patients at home. As such, there is a need to develop a risk stratification model for patients at home to predict
worsening conditions and alert clinicians accordingly.

A TECHNOLOGY DRIVEN SOLUTION
As mentioned in the previous sections, patients when they are discharged after treatment for CHF, are often given written and
verbal instructions to promote self-care. There are many problems with this approach as is evident with the very high
readmissions rate [8,9]. When investigated further regarding the root cause of this problem, two broad factors [6] immediately
stand out:

Lack of understanding – These patients often do not understand the instructions because of a host of factors like lack of
education, literacy level, age, poor economic conditions, self confidence, self perceived health and self efficacy.

Lack of Motivation – The patient's willingness to change and get better is low because of low social support and social isolation,
physical limitations, distressed emotions resulting in difficulties dealing with treatment.

Many care giving facilities acknowledge this problem, and make an effort to assign nurses or other care-givers to help these
patients adhere to prescribed medications and behavior change like diet and exercise. But despite best efforts, the hospitals and
the patients fail to achieve the desired outcomes. Lack of resources, money and trained personnel are often cited as primary
reasons for this failure.

Given this situation, the obvious solution is a technology based intervention, and if inspiration can be drawn from pioneering
work done by B.J. Fogg in the field of Persuasive Technology, especially his eight step design process [14] on how to design and
create Persuasive Technologies, both the problems stated above can be addressed.

PERSUASIVE TECHNOLOGY
B.J. Fogg talks about the best practices for designing Persuasive Technology based intervention, and outlines eight steps [14,16].
The steps as illustrated in Figure 2 are as follows:

1. Choose a simple adherence behavior to target: The first step in designing a successful persuasive technology is to select an
appropriate behavior to target for change. We should select the smallest, simplest behavior that matters. Often this requires us
to reduce the big goal to a small, seemingly tiny, objective.
2. Choose a receptive audience: Step 2 in the persuasive design process involves choosing the right audience for the
intervention, if at all possible, an audience that has a need and hopefully has the motivation for change.
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3. Find what prevents the target behavior: Once the appropriate behavior and audience to target is selected, it’s time to move on
to Step 3. In this step we must determine what is preventing the audience from performing the target behavior. The answers to
such questions always fall into some combination of the following three categories:
I.

lack of motivation

II. lack of ability
III. lack of a well-timed trigger to perform the behavior
4. Choose a familiar technology channel: Once it is identified what is preventing people from adopting the target behavior, we
can move on to Step 4: choosing the best channel for the technology intervention. Which channel is “best” usually depends
on three factors:
I.

the target behavior

II. the audience
III. what is preventing the audience from adopting the behavior— i.e., the first three steps in the design process.
5. Find relevant examples of persuasive technology: In Step 5 of the design process, we should search for examples of
successful persuasive technologies that are relevant to the intervention.
6. Imitate successful examples: The next step in the persuasive design process is to imitate what’s working in the successful
examples gathered in Step 5.
7. Test and iterate quickly: After we have found ways to imitate successful examples of persuasive technology, the next step is
to test various persuasive experiences quickly and repeatedly. A series of small, rapid tests will teach more than one big test.
Each test should take only a few hours, start to finish. These are not scientific experiments but quick trials that allow us to
prototype the experience and see how people react. We should assess the response, ideally by measuring behavior.
8. Expand on success: Creating a persuasive technology that changes a behavior, no matter how small or simple, is a milestone.
In Step 8, we can expand on this success. Now is the time to scale up.
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Figure 2: Eight Steps in Early Stage Persuasive Design (Source: B.J. Fogg Paper [14])
It is also important to understand what causes a person to change his behavior, and B.J. Fogg's "Behavior Change Model" [15]
can provide deep insight in this regard.

The Model, B=MAT has fundamentally changed how people approached and designed Persuasive Technology interventions. He
argued that three elements must converge at the same moment for a behavior to occur: Motivation, Ability, and Trigger. When a
behavior does not occur, at least one of those three elements is missing.

1. Motivation – three core motivators with two sides exists
I.

Sensation – pleasure/pain

II. Anticipation – hope/fear
III. Social cohesion – acceptance/rejection
2. Ability – make behavior simpler to do
3. Triggers – we are surrounded by triggers (cue, prompt, call to action, request)

Figure 3 illustrates the model
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Figure 3: Behavior Change Model (source www.behaviormodel.org [15])
Nir Eyal in an article on Chatbots Magazine, titled "Bots and A.I. In Behavioral Concept" [65] says, triggers and habits are
psychological concepts that must be understood first. Triggers for the users can be loneliness, eagerness, satisfaction, uncertainty,
or curiosity. Also habits comes from the repeating actions from the mental experiences. "It’s about the feelings in the end", says
Nir. Therefore, bot makers or A.I. system designers should think where the feelings should be put into the system and extract data
from the people’s behaviors. Observation and empathy are the most needed skills for designing the system of the bot, basically.

A CONVERSATIONAL AGENT - DIL
A conversational agent is a software program which interprets and responds to statements made by users in ordinary natural
language. It integrates computational linguistics techniques with communication over the internet. The term Conversational
Agent is primarily used in an academic context by scientists and engineers working on these systems to ensure satisfactory and
relevant interaction with the user. They focus on developing interactive embodied conversational agents (ECA) and improving
verbal and nonverbal human-computer interaction [58]. A conversational agent (CA) can also be considered a dialogue system. It
is in essence a computer system intended to converse with a human with a coherent structure. Dialogue systems have employed
text, speech, graphics, haptics, gestures, and other modes for communication on both the input and output channel [59].

The idea of a Conversational Agent based intervention for chronic disease management is not new. Research has shown large
success in achieving behavioral change with this kind of approach. Chatbots also represent opportunities for positive social
impact. Chatbots can make needed services more accessible, available, and affordable. They can strengthen users' autonomy,
competence, and (possibly counter-intuitively) social relatedness [64]. Conversational agents can serve as powerful technological
mediators to impact motivational outcomes such as self-efficacy and attitude change [24]. The Conversational Agent based
intervention has been tried in a variety of settings from Alcohol consumption [25], promoting health behavior change in heart
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attacks [26], psychosocial intervention deployed on hand-held computers [27], hospital discharge nurse that explains written
hospital discharge instructions to patients with low health literacy [23], psychotherapy [28], and as health dialog systems [29].
Ferguson et. al. proposed CARDIAC: An Intelligent Conversational Assistant for Chronic Heart Failure Patient Heath
Monitoring, that can conduct regular “checkup” interviews with patients to collect information relevant to their condition [39].
Lisetti et. al. proposed an architecture for building an On-Demand Avatar-Based Health Intervention for Behavior Change [34].

Behavior change is a multi-step process. It begins with raising awareness by inspiring the curiosity, engaging the interest, and
identifying the motivations of a target audience [63] . Through nudges like timed reminders, prompts, and challenges, chatbots
can potentially inspire patients to adopt a more positive outlook towards and behavior.

Preliminary Results of a Randomized Controlled Trial on Childhood Obesity using a Text-based Healthcare Chatbot (THCB) [66]
with 15 patients indicate promising results with respect to intervention adherence (13.000 conversational turns over the course of
4 months or 8 per day and patient), scalability of the THCB approach (99.5% of all conversational turns were THCB-driven) and
over-average scores on perceived enjoyment and attachment bond between patient and THCB.

According to a survey of 100 practicing physicians all across the United States [60], many physicians believed in both costs and
benefits associated with chatbots, depending on the logistics and specific roles of the technology. Chatbots may have a beneficial
role to play in health care to support, motivate, and coach patients as well as for streamlining organizational tasks; in essence,
chatbots could become a surrogate for non-medical caregivers. However, a lot of skepticism remain among the physicians on the
efficacy of using Chatbots in self care management. Based on the findings of the survey results [60], many physicians believed
that chatbots cannot effectively care for all of the patients’ needs (76%, 76/100), cannot display human emotion (72%, 72/100),
and cannot provide detailed diagnosis and treatment because of not knowing all of the personal factors associated with the patient
(71%, 71/100). Many physicians also stated that health care chatbots could be a risk to patients if they self-diagnose too often
(74%, 74/100) and do not accurately understand the diagnoses (74%, 74/100) [60].

Previous studies and literature especially in chronic disease management have clearly outlined a tremendous need for
technological interventions especially in the areas of self care and self management of chronic diseases to ease the caregiver
burden since human support cannot scale with the growing population living with CVDs. A recent study showed ninety million
Americans have inadequate health literacy, resulting in a reduced ability to read and follow directions in the healthcare
environment [23]. A large section of these patients fall through the crack, cannot follow through the behavioral guidelines as
prescribed because of a lack of understanding, education, social isolation, or simply motivation to do better, and resource
constraints of the hospitals and clinics. It is this gap that a Conversational Agent can address.
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In this research, the researcher takes inspiration and ideas from the work in various fields as mentioned above and in subsequent
sections, and design and implement DIL – a Conversational Agent, in the specific domain of Heart Failure Patients to address the
problems and issues discussed above. In particular, this is an agent that works in conjunction with the 'Home Monitoring' system
[32]. DIL would review Home monitoring dashboard results, and have conversations with patients. Techniques like Motivational
Interviewing (MI) to persuade patients to adhere to clinical guidelines and better behavioral outcomes by using a combination of
persuasive messages and pictures, inspirational videos, and healthcare articles.

2.2 THEORETICAL UNDERPINNINGS
Consolvo et. al. [17] used concepts from behavioral and social psychological theories to shape an understanding of how to design
technology to support behavior change while supporting fundamental social needs. In this paper, four distinct theories provide
inspiration and form the foundation for designing technologies that motivate behavior change in everyday life. The four theories
are:

1. Reinforcement Theory [18,19]
2. Social Cognitive Theory [36, 37, 38]
3. Adherence and Health Outcomes: How much does Adherence Matter [20]
4. Cognitive Dissonance Theory [22]

REINFORCEMENT THEORY
Reinforcement theory [18] of motivation was proposed by BF Skinner and his associates. It states that individual’s behavior is a
function of its consequences. It is based on “law of effect”, i.e, individual’s behavior with positive consequences tends to be
repeated, but individual’s behavior with negative consequences tends not to be repeated.

Reinforcement theory of motivation overlooks the internal state of individual, i.e., the inner feelings and drives of individuals are
ignored by Skinner. This theory focuses totally on what happens to an individual when he takes some action. Thus, according to
Skinner, the external environment of the organization must be designed effectively and positively so as to motivate the employee.
This theory is a strong tool for analyzing controlling mechanism for individual’s behavior. However, it does not focus on the
causes of individual’s behavior.

12

Figure 4: Reinforcement Theory - Operant Conditioning, (Source -B.F. Skinner [18])

SOCIAL COGNITIVE THEORY
Social cognitive theory (SCT) refers to a psychological model of behavior that emerged primarily from the work of Albert
Bandura [36, 37]. Initially developed with an emphasis on the acquisition of social behaviors, SCT continues to emphasize that
learning occurs in a social context and that much of what is learned is gained through observation.

SCT rests on several basic assumptions about learning and behavior. One assumption concerns triadic reciprocality, or the view
that personal, behavioral, and environmental factors influence one another in a bidirectional, reciprocal fashion. That is, a
person's ongoing functioning is a product of a continuous interaction between cognitive, behavioral, and contextual factors. For
instance, classroom learning is shaped by factors within the academic environment, especially the reinforcements experienced by
oneself and by others. At the same time, learning is affected by students' own thoughts and self-beliefs and their interpretation of
the classroom context.

A closely related assumption within SCT is that people have an agency or ability to influence their own behavior and the
environment in a purposeful, goal-directed fashion [38]. This belief conflicts with earlier forms of behaviorism that advocated a
more rigorous form of environmental determinism. SCT does not deny the importance of the environment in determining
behavior, but it does argue that people can also, through forethought, self-reflection, and self-regulatory processes, exert
substantial influence over their own outcomes and the environment more broadly.

A third assumption within SCT is that learning can occur without an immediate change in behavior or more broadly that learning
and the demonstration of what has been learned are distinct processes. One reason for this separation is that SCT also assumes
that learning involves not just the acquisition of new behaviors, but also of knowledge, cognitive skills, concepts, abstract rules,
values, and other cognitive constructs. This division of learning and behavior is a shift from the position advocated by behavioral
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theories that defined learning stridently as a change in the form or frequency of behavior. It also means that students can learn but
not demonstrate that learning until motivated to do so.

ADHERENCE
MATTER?

AND

HEALTH OUTCOMES: HOW

MUCH DOES

ADHERENCE

Patient adherence (also known as patient compliance) involves the degree to which patients follow their medical provider's
recommendations for varied health regimens, including taking medications, making changes to diet, exercising, attending followup appointments, completing screenings, and attending to a host of lifestyle changes and treatment activities. Rates of nonadherence vary widely across diseases conditions and treatment requirements, but on average, at least a quarter of patients are
non-adherent [44].

The relationship between patient adherence and treatment outcomes is critically important to examine in a range of disease
realms, where the requirements of adherence and the potential for its benefit vary widely. Studies of Heart disease and myocardial
infarction (MI), for example point to a strong relationship between adherence and mortality risk. Specifically, patients whose
adherence to the medication clofibrate was at least 80% had a lower risk of death over ensuing 5 years [20].

Medication non-adherence among heart transplant patients has been found to predict adverse outcomes. This serious medical
procedure requires complex follow-up care that can mean the difference between transplant success and failure. [20].

Factors leading to better adherence may include positive provider-patient interactions and communication and greater confidence
in one's ability to adhere. As observed in many clinical cases, it is rational to predict that effective and positive provider-patient
communication is associated with better adherence and ultimately with improved treatment outcomes.

Many quantitative reviews have been conducted to assess the relationship between adherence and health outcomes. One of the
earliest reviews of this relationship included six studies and demonstrated that adherence was related to positive health outcomes
in five out of six investigations [46]. A meta-analysis of the relationship between adherence and outcomes across diseases
indicated that the odds of a good health outcome are 2.88 times higher if a person is adherent and that there is a 26% greater risk
of poor health outcomes in the context of non-adherence [47]. Additional quantitative review has shown a relationship between
adherence and the ultimate outcome, lower mortality risk. A meta-analysis of 21 studies of adherence to drug therapy showed
significantly lower probability of death among good adherers than among those who were "poor" adherers [48].
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COGNITIVE DISSONANCE THEORY
Cognitive Dissonance Theory [22,17] explains what happens when an individual realizes that her attitudes and behaviors are
inconsistent. When that happens, the individual will experience psychological discomfort (or dissonance). Because this
dissonance is psychologically uncomfortable, the individual will be motivated to reduce or eliminate the dissonance. Her
motivation depends on how important the beliefs or behaviors are to her. That is, the more important they are to the individual,
the more likely she will try to reduce or eliminate the dissonance.

When an individual is motivated to reduce or eliminate dissonance, she can change her behavior or knowledge. She may also
reduce the importance of the dissonance by actively learning about other things that are more harmful than whatever is causing
the dissonance or by actively avoiding information or situations that may produce (or reinforce) the dissonance. Cognitive
Dissonance Theory suggests that a persuasive technology to encourage lifestyle behavior change should address whichever
factors may prevent the individual from incorporating the change into her everyday life (i.e., by helping her change her behavior
to match her attitudes). For example, the technology should help the individual remain focused on her commitment to change and
her relevant patterns of behavior. The awareness provided by the technology should be persistently available and easy to access,
yet subtle enough so as to support occasional needs for information/situation avoidance.
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C HAPTER 3: METHODOLOGY
3 .1 G O A L S , O B J E C T I V E S A N D R E S E A R C H Q U E S T I O N S
GOALS

As mentioned above, patients routinely fail to follow the guidelines given to them at the time of discharge, and despite best
intentions, the nurses cannot follow up with every patient because of resource problems. So, the goal of this research is to
explore:

1. The reasons why patients fail to adhere to clinical and behavioral guidelines.
2. If a Conversational Agent can alleviate the resource problem?

OBJECTIVES
The objectives of the proposed research is to design a Conversational Agent based health-worker that can chat multiple times a
week and can perform the following:

1. Carry on a conversation with patients in an empathetic way.
2. Find out and document the reasons patients fail to adhere to clinical and behavioral guidelines.
3. Provide reminders to patients when they forget to perform their prescribed routine tasks.
4. Provide continuous encouragement and motivation to reach desired health goals by sticking to behavioral guidelines
prescribed by the clinician.
5. Evaluate the efficacy and utility of such a Conversational Agent; specifically on the quality of life, which will be measured by
using the "Minnesota Quality of Life" questionnaire (Appendix C).

RESEARCH QUESTIONS
The research questions that will guide this study can be broadly classified under three different areas of interest:

1. Human Computer Interaction:
1. Research Question 1: How much engagement can DIL elicit? – The proposed system will track and measure the
following:
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I.

How many times the patients responded to chat messages from DIL?

II. What was the typical duration of a chat session?
III. A post survey to get qualitative feedback from the patients.
2. Complimenting Human Nurses and Case Workers
I.

Research Question 2: Can DIL be a persuasive communication tool? It will be extremely interesting to find out if the
patients will be as receptive chatting with DIL as they will be talking with humans – The research will compare results
from before and after the implementation of the proposed system, and measure improvements in compliance score, if any,
to determine the effectiveness of the DIL as an effective tool for persuasion, and elicit compliance to clinical and
behavioral guidelines.

II. Research Question 3: Can an Assistive Technology like DIL lower the Caregiver burden in scaling with a large
population? – An exit-survey of the patients to determine the Perceived Helpfulness of DIL will be used to gauge how the
users felt interacting with DIL

3.2 RESEARC H APPROAC H
This study used a design science research approach to address the research questions. Hevner and Chatterjee (2010) [30], explain
that the DSR approach is an iterative process that includes three cycles as follows:

1. Relevance Cycle is where the contextual environment of the research project impacts the design science activities.
2. Rigor Cycle is where the knowledge base of scientific foundations, experience, and expertise influence the design science
activities.
3. Design Cycle is where building and evaluating the design artifacts happens. Starting from the application context, the
relevance cycle starts when the research requirements (opportunity and problem) and the acceptance criteria for evaluation
are identified. These requirements and criteria continuously changed as the artifact "DIL" was being built and evaluated.
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Figure 5 [31] illustrates the three cycles:

Figure 5: Design Science Research Framework (Source: [31])
The Design Science Research (DSR) Checklist proposed by Hevner and Chatterjee [30] was used to evaluate the research. The
questions in Table 2 provide such a checklist that was used to assess progress, and to ensure that the research addressed the key
aspects of design science research.

Table 2: DSR Checklist
#

Questions

Answers

1

What is the Research Question (design requirements)?

Stated on Page 25 & 26.

2

What is the Artifact? How is the artifact represented?

A DIL/Conversational Agent – Page
19-21 and 28-34

3

What Design Processes (search heuristics) will be used
to build the artifact?

Design and Build – Pages 28-34

4

How are the Artifact and the Design Processes
grounded by the knowledge base? What, if any,
theories support the artifact design and the design
process?

Theoretical Underpinnings – Pages 21-24

5

What Evaluations are performed during the internal
design cycles? What design improvements are identified
during each design cycle?

Evaluations – Pages 39-59

6

How is the Artifact introduced into the application
environment and how is it Field Tested? What Metrics
are used to demonstrate artifact utility and improvement
over previous artifacts?

Evaluations – Pages 39-59

7

What new Knowledge is added to the knowledge base
and in what form (e.g. peer- reviewed literature, metaartifacts, new theory, new method)?

Conclusions for Research Questions,
Practice Implications, Future Research Pages 61-68

8

Has the Research Question been satisfactorily
addressed?

Conclusions for Research Questions Pages 61-64

Table 2: DSR Checklist
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To demonstrate the relationship of these questions with the three research cycles discussed in the previous section, Figure 6 [30]
maps the eight questions to the appropriate research cycle.

Figure 6 - DSR Checklist mapped to DSR Cycles

DESIGN &

BUILD

The Design Artifact, DIL is designed to specifically target Heart Failure patients. It builds on the "MyHeart" system, a
collaboration between the IDEA Lab at CGU, and Loma Linda University Hospital.

The MyHeart Home Monitoring system [32] was geared towards Home Monitoring to promote self-care adherence. Every CHF
patient participating in trial when discharged from Loma Linda Hospital were given a set of instructions that may include specific
guidelines on diet, exercise and medications, as they transition from Hospital care to Home care. The Home monitoring system
deployed a set of tools and took advantage of an Expert System that monitored remotely the patients adherence to the prescribed
instructions. This tele-monitoring system captured various vital data, and updated on a patient dashboard that was then used by
the hospital staff, clinicians and nurses to follow up on the progress of these discharged patients.

DIL employs this MyHeart system to collect patient health data on a regular basis. The patients were all given a set of homemonitoring devices like a Bluetooth enabled weigh scale and a blood pressure monitor. The conversational agent DIL will then
evaluate the dashboard of patient health data, and use that data for conversation with patients.
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Figure 7 shows the Home-Monitoring Dashboard:

Figure 7: Home Monitoring Dashboard
A review of this dashboard data shows that a majority of the patients fail to live up to the required guidelines for a variety of
factors outlined in the Problem Statement section. The hospital staff want to know the reasons for non-adherence, but struggle to
routinely follow up with these large group of patients, for a number of reasons, more specifically lack of resources and money. It
is this gap, that DIL hope to fill.

Figure 8 demonstrates DIL Conversation and Process Flow:

Figure 8: DIL Conversation and Process Flow
A conversation between DIL and the patients happens multiple times a week. DIL has the intelligence to carry on a conversation
that is tailored to each patient's specific needs. A typical conversation starts with a "Welcome" message and a review of the
Dashboard results. The conversation will then transition to the positive aspects of the dashboard results, congratulate the patient
on a job well done with positive reinforcements. The next step will be to review the negatives, find out why the patient is unable
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to fulfill the requirements, and enquire about the barriers. At every step, lessons learned from previous research on Persuasive
Technology, and Conversational Agents were used to motivate the patient to do better, and achieve the desired outcome of full
compliance to the prescribed instructions at the time of discharge.

Here are some screenshots that show a typical Patient - DIL conversation:

Figure 9: DIL Welcome Screen

Figure 10: DIL Review Dashboard Data
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Figure 11: Discuss Systolic BP

Figure 12: DIL Review Systolic BP Data
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The conversation goes on from there. Of course, the conversation can also branch out to other areas based on the user's responses.
For example if the patient was out of medications, and that was the reason for not taking the prescribed drugs, it will be a very
different conversation.

The conversations are recorded for further review by a nurse and clinician for two main reasons:

1. To remove any errors in interpretation by the system.
2. To improve the system's future conversational capabilities.

The Researcher foresees DIL taking on more responsibilities with advancement of technology. A future enhancement can
potentially be to mimic the Provider for Patients at different risk levels, and ask natural questions that a trained provider - a nurse
or a doctor might ask.
SYSTEM ARCHITECTURE
This research is problem-solving in essence, being as it is about designing and building an ICT-based intervention to help solve
the self-care needs of patients.

DIL is not envisioned to replace a human intervention, but rather to complement any human intervention. It is one extra tool to
address the limited resource problem that is very apparent in current scenario.

The real-world design of DIL incorporates a combined strategy design that starts with a flexible design and uses exploratory
interviews and empirical data to understand the processes and people and is followed by a fixed design phase that incorporates a
focused experiment [33].

First, it defines the problem, giving due consideration to barriers to self-management and the burden of Heart failure on patients,
their families, and society at large. It then demonstrates, through a review of behavioral science theories relevant to the problem
of motivating sustained Heart Failure self-management activities as well as existing IS research in the problem domain, the
inadequacy of existing solutions to the problem. Thereafter, it develops and presents a purposeful IT artifact that adequately
addresses the knowledge gap and solves the problem. The artifact is then evaluated through an experimental study. Finally the
significance, contributions, and implications of the study to IS research as well as to the problem environment and the society at
large are communicated through a dissertation report.

Like all Design Science projects, the design and development of DIL also went through multiple iterations, trials and errors. At
the inception stage, the idea was to have a voice enabled bot with Artificial intelligence. Technologies like Nuance Mix were

23

explored for Text-to-Speech and Speech-to-Text conversions using Mix.nlu for natural language understanding and processing.
Although the Nuance platform has big advantages like cross-platform support and support for multiple languages, development
on the platform has a significant learning curve. A prototype was developed and discarded as the bot never functioned as desired;
there were many issues with text-to-speech and speech-to-text conversions that needed further research and knowledge of the
platform to solve. It was often the case that the bot did not understand human utterances, and needed further training.

The researcher also explored the Azure Bot services; Microsoft has excellent documentation and tutorial videos to help
developers create intelligent bots using LUIS (Language Understanding Intelligent Services) framework. Azure Bot service also
has support for multiple channels where the bot can be deployed. The prototype developed used Skype to communicate with
users. The system showed much promise, but still had room for improvement especially with understanding voice resulting in
errors in Speech-to-text conversions. At the time Azure Bot Services were not free, and the investment required in terms of
money and time to master and develop a sophisticated bot was beyond the scope of a Dissertation project.

After investing about nine months trying to develop a functional voice-enabled bot that never livd up to expectations, the
researcher went back to the drawing board, and decided to simplify the project and limit its scope by making it a chatbot.
According to Nir Eyal in an article in Chatbots Magazine titled, "Bots and A.I. In Behavioral Concept with Nir Eyal", ”Of all the
ways humans communicate, texting might be the most direct. Text carries less superfluous information than other ways of
sending information. With text, there are no voice intonations to decipher or accents to understand, no facial gestures to interpret,
and no body language to translate. Text is something computers can understand and process quickly and it’s why messaging is a
great place for humans and A.I. to work together to serve customer needs.” [65].
The researcher still plans to have a voice enabled bot as a future version of the current project that can be taken up after the
dissertation is complete. The current iteration of DIL had three primary design objectives:
• It must be easy to use
• It can be deployed in the shortest time possible
• It must be easily deployable on a platform that most users are familiar with.

With these design objectives in mind, the researcher finally chose the Chatfuel development platform, and Facebook Messenger
as the deployment platform. Chatfuel is the world's leading chatbot platform for Facebook Messenger; the development
environment is mostly drag and drop building blocks that can be build and deployed in really quick time. With more than 2.4
billion active monthly users, Facebook and Facebook Messenger is widely popular and most users are extremely familiar with the
platform. This minimizes the learning curve for the users to use such a system. Facebook Messenger also has cross-platform
support - it works seamlessly on both iOS and Android based mobile phones and on desktop. Chatfuel offers basic artificial
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intelligence support, but keeping future needs and visions for the system in mind, provisions were made for Natural Language
Processing (NLP) and Artificial Intelligence (AI) module by integrating with Google's AI.API.

So, DIL is in essence a "Chat-Bot" system, that uses the Facebook Messenger platform to communicate with the patient. The
fundamental architecture of DIL draws inspiration from [34, 39], and uses Motivational Interviewing (MI) [35].

Figure 13 shows the System architecture:

Figure 13: DIL System Architecture
As mentioned in previous sections, DIL uses the Home monitoring dashboard and the MyHeart system as a starting point, and
builds on it. All patients were given a set of home monitoring devices to measure health data like a blue-tooth enabled weight
scale and a blood pressure monitor. The patients were also given a Android based tablet with the MyHeart app installed. A unique
profile was created for every patient. The MyHeart app would collect the data whenever the patients measured weight, blood
pressure and pulse rate. The users also answered some symptomatic questions like sleep and restlessness, fatigue and tiredness,
shortness of breath, swollen ankles etc. - symptoms that could be critical indicators that something was nice. These health data
were uploaded to patient health dashboard (Figure 7). DIL reviews this dashboard data to initiate conversations with patients
(figure 8). DIL uses the MyHeart rule based Expert System [32] to determine patient's risk profile, and customizes the
conversation using MI [35] and other persuasive techniques like motivational messages, photos, videos and healthcare articles.
The ultimate goal is to provide positive reinforcements for patients who are doing well, and motivate people who are not doing so
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well to do better, and hopefully achieve that by promoting behavior change like controlling diet, exercising daily, and taking
medications on a timely manner.

3.3 RESEARCH DESIGN
In this study, the researcher conducted an investigation to test the null hypothesis that there is no difference in health and
behavioral outcomes due to intervention of a Conversational Agent based IT artifact like DIL.

Participants in the trial were all heart-failure patients at various stages of recovery. They were monitored for two weeks prior to
DIL's intervention. These patients all used the Home Monitoring system [32]. They used the MyHeart [32] application in
conjunction with bluetooth enabled self monitoring devices like a weight scale, a blood pressure monitor and uploaded the data
using a tablet to a health dashboard (figure 7). The patients all answered 21 questions of the "Minnesota Living With Heart
Failure" questionnaire (see Appendix C) at the beginning of the trial to gauge an understanding of the quality of life.

Figure 14 shows a typical Home monitoring setup.

Figure 14 - Home Monitoring setup [32]
DIL intervened at the end of two weeks, and conversed with patients multiple times a week for the next 4 weeks. During this time
the patients continued to use the Home Monitoring system, measured and uploaded their health data to the Health dashboard.

At the end of the trial, the Patients once again answered the "Minnesota Living with Heart Failure" questionnaire (Appendix C).
They also participated in two surveys - a "DIL User Satisfaction & System Usability" survey (Appendix A) and a second survey
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on the "Perceived Helpfulness of DIL" (Appendix B). The Researcher compared the Health dashboard data before DIL's
intervention to the dashboard data during intervention.

Quantitative data was collected by comparing Health dashboard data, from the "Minnesota Living With Heart Failure"
questionnaire, and from the "DIL Usability survey." Qualitative data was obtained from the "Perceived Helpfulness of DIL"
survey. Survey items included patient's feedback on the design and usability of the IT artifact DIL, and questions about patient
perceptions and experiences.

To determine if there is a difference in health and behavioral outcomes, a study comparing Health data before and after DIL's
intervention was needed; therefore, the most appropriate research strategy was mixed-method design. According to Creswell,
triangulation mixed-methods design enables the concurrent collection of quantitative and qualitative data and comparison [49].
Concurrent triangulation design will enable the researcher to use separate quantitative and qualitative methods to assess and
cross-validate the results of the data collection [50]. Johnson and Onwuegbuzie (2004) [51] and Ercikan and Roth (2006) [52]
asserted both quantitative and qualitative methods have merit and advocated that the best research design is mixed methods.
“Both quantitative and qualitative researchers describe their data, construct explanatory arguments from the data, and speculate
about why the outcomes they observed happened as they did” (Johnson & Onwuegbuzie, p. 15) [51]. “Gaining an understanding
of the strengths and weaknesses of quantitative and qualitative research puts a researcher in a position to mix or combine
strategies and to use the fundamental principal of mixed research” (Johnson & Onwuegbuzie, p. 18). Thus, the most ideal
research method was a mixed-method design through which the researcher was able to have the knowledge gained by qualitative
as well as quantitative research.

3.4 DATA COLLECTION PROCEDURES
INSTRUMENTATION
The following instruments were used to collect data during the trial:

•

Patients completed the Minnesota Living with Heart Failure questionnaire (MLHFQ) at the beginning of the trial, and again at
the end of the trial.

•

Health vital data like weight, blood pressure and pulse readings were monitored, and recorded on the Home monitoring
dashboard. The data for two weeks before DIL's intervention were compared to data for four weeks during DIL's intervention,
mean scores for patients were calculated and a paired t-test was conducted for statistical significance.

•

A post-trial survey on the "User satisfaction and System Usability" was completed by the every patient.
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•

Each patient also completed a post-trial survey on the "Perceived helpfulness of DIL."

TREATMENTS
Each patient was given a training on the use of Home monitoring devices like weight scale, blood pressure monitor, and the use
of the MyHeart app on the tablet to record the measurements. The patients were also trained on the IT artifact DIL; accounts were
setup for using DIL and the MyHeart app.

SURVEY ADMINISTRATION
The patients filled out the Minnesota Living Heart Failure survey by hand, and completed the other two surveys online that were
specifically designed for this research on Qualtrics.

IRB - INSTITUTIONAL REVIEW BOARD - CL AREMONT GRADUATE UNIVERSIT Y
The design research plan for the system was reviewed by the Institutional Review Board (IRB) at Claremont Graduate University.
CGU Human Subjects Protection Staff members reviewed the study and determined it to be exempt from IRB supervision on
March 28, 2018 (Appendix D).

3 . 5 DATA A N A LY S I S
STUDY

PARTICIPANTS

Five heart-failure patients participated in the study. They were recruited by reaching out to known physicians, friends and family.
Each patient completed the entire duration of the trial, which included measurement of weight, blood pressure and pulse readings
using bluetooth enabled weight scale and blood pressure monitors, and answering health symptom questions. The patients used
an Android powered tablet and the MyHeart app to collect and upload these data to the Home monitoring dashboard (figure 7)
[32].

The patients also completed the "Minnesota Living with Heart Failure" questionnaire (see appendix C) before and after the trial.
At the conclusion of the trial, they participated in two surveys - the "DIL Usability" survey, and the "Perceived Helpfulness of
DIL" survey (see appendix).

28

A N A LYS I S

OF

RESEARCH QUESTIONS

RESEARCH QUESTION 1
How much engagement can DIL elicit?

The conversation between DIL and the patients were recorded for data analysis purposes. A broadcast message from DIL was sent
to patients everyday at 8:00 pm. The patients typically responded and conversed with DIL about 3 times a week.

The chat session duration varied slightly from person to person with the mean time spent at 18 minutes per session.

A post survey on User's satisfaction of DIL (see appendix A) was also used to gauge Patients' experience with DIL.
RESEARCH QUESTION 2
Can DIL be as persuasive as a human health care worker?

The researcher wanted to find out if the patients will be as receptive chatting with DIL as they will be talking with humans. The
research compared results from before and after the intervention of DIL, and measured improvements in health and behavioral
outcomes, if any, to determine the effectiveness of the DIL as a tool for persuasion, and elicit compliance to clinical and
behavioral guidelines.

The researcher used quantitative data by comparing before and after scores of health parameters on the health dashboard (figure
7), and quality of life scores by using the "Minnesota Living with Heart Failure" questionnaire (Appendix C). A paired T-test is
the ideal statistical measure to compare before and after scores within the same group as in this case, and was used to test the Null
Hypothesis, "there is no difference in health and behavioral outcomes due to intervention of a Conversational Agent based IT
artifact like DIL."
RESEARCH QUESTION 3
Can an Assistive Technology like DIL lower the Caregiver burden in scaling with a large population?

The researcher also wanted to determine if DIL can fill the gap of scalability of human support, and its effectiveness. To that
effect it was important to find out what the patients felt about interacting with DIL, and their experience. Did they find DIL
helpful in achieving better health and behavioral outcomes, was extremely important to know because if DIL can complement the
efforts of the caregiver community, and motivate people to do better, then the fundamental problem of resource constraint is
addressed to a large extent. The researcher used Qualitative data - a post-trial survey, "Perceived Helpfulness of DIL" (see
Appendix B) to gather patients' feedback.
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C H A P T E R 4 : R E S U LT S
As stated in Chapter 1, the purpose of this study is to evaluate the artifact, DIL, a conversational agent for heart-failure patients.
Can DIL elicit behavior change, and better adherence to clinical guidelines for the patients in the study group were the driving
question for this research. The study used a mixed-methods design to explore the research questions as completely as possible.
Chapter 4 presents a summary of the data collected during the study.

4 .1 PA R T I C I PA N T D E M O G R A P H I C S
There were five participants in the trial. The participants ranged in age; they were all male. Table 3 shows the Patient age groups.
All the patients belonged to the Asian American community, and lived in Southern California.

Table 3 - Participant Age Group
Age
Participants

40-50

50 +

3

2

Table 3: Participant Age Group

4.2 FINDINGS FOR RESEARCH QUESTION 1
ENGAGEMENT
The patients typically chatted with DIL about 3 times a week. Each chat session reviewed the latest health dashboard data.

Figure 15 shows Patient Responses. The patients conversed on a variety of different topics ranging from fluctuation in weight,
Systolic and Diastolic Blood pressure, diet, exercise, and medicine. Over a four week period during DIL's intervention, DIL sent
messages to the patients every day for four weeks. Every patient's response rate was different, which was expected. Patient 1
responded 26 times, while patient 5 responded 11 times.
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Figure 15: Patient Responses

The response percentage varied from 93% at the high end to 39% at the low end. The mean patient response rate was 62.14%.
The Response Rate is shown in Figure 16.
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Figure 16: Patient Response Rate
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To accurately measure Patient Engagement, the Patient responses and response rate is not enough. It is important to see how
much time the patients spent with DIL. As mentioned before, DIL sent a message to the patients everyday at 8:00 PM. The
average time spent conversing with DIL varied slightly from patient to patient with 20 minutes at the high end for patient 4 to 15
minutes at the low end for patient 2. The average chat duration with DIL is 18 minutes. Figure 17 shows the Chat Duration by
patients.

Figure 17: Patient Chat Duration

USER SATISFACTION
Each of the patients took an exit survey and provided feedback on their satisfaction level and the usability of the system. The
survey consisted of 21 questions; the questions were specially selected based on QUIS and System Usability Scale.

Tables 4 through 8 shows the results and individual scores for every patient after completing the survey. The individual patient
score calculation is a slightly modified version of the System Usability Score calculation based on a 10 question survey on a
Likert scale of 1-5 [53,54], and were calculated in the following way:

•

For each of the odd numbered questions, 1 was deducted from the score.

•

For each of the even numbered questions, the patient response value was deducted from maximum score possible (9 for Qs
1-19, 10 for Qs 20 & 21).

•

The scores were then added and multiplied by 2.
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•

This total score was then divided by the maximum number of points possible (9x19 + 2x10 = 191)

A score of 80 and above is an 'A' - the patients love the IT artifact, and will most likely recommend the system. A score of 68 is
generally considered the average score - a 'C', which means usability of the system is OK but could improve. A score of 51 or
under is 'F', which means usability has to be a priority and needs to be fixed.

Table 4: DIL User Satisfaction & System Usability
After DIL's Intervention - Patient 1
Question

Patient Response

Patient Score

1 Design

9.00

8.00

2 Difficulty

9.00

0.00

3 Usability

9.00

8.00

4 Reading Characters on Screen

9.00

0.00

5 Organization of Information

8.00

7.00

6 Sequence of Screens

8.00

1.00

7 Use of terms throughout system

8.00

7.00

8 Terminology related to task

9.00

0.00

9 Position of messages on screen

9.00

8.00

10 Prompts for input

9.00

0.00

11 Error Messages

8.00

7.00

12 Learning to operate the system

9.00

0.00

13 Performing tasks straighforward

9.00

8.00

14 Help messages on screen

9.00

0.00

15 Supplemental reference materials

8.00

7.00

16 System speed

9.00

0.00

17 System reliability

8.00

7.00

18 Correcting your mistakes

9.00

0.00

19 Designed for all levels of users

9.00

8.00

20 I will use the system frequently

10.00

0.00

21 I felt very confident using the system

10.00

9.00

Total Possible Score (19*9 + 2+10) = 191

185.00

170.00

Questions 1-19 - scale of 1 through 9
Questions 20 & 21 - scale of 1 through 10

0.97

0.89

Table 4: DIL User Satisfaction & System Usability After DIL's Intervention - Patient 1
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Table 5: DIL User Satisfaction & System Usability
After DIL's Intervention - Patient 2
Question

Patient Response

Patient Score

1 Design

8.00

7.00

2 Difficulty

7.00

2.00

3 Usability

8.00

7.00

4 Reading Characters on Screen

9.00

0.00

5 Organization of Information

7.00

6.00

6 Sequence of Screens

8.00

1.00

7 Use of terms throughout system

7.00

6.00

8 Terminology related to task

8.00

1.00

9 Position of messages on screen

8.00

7.00

10 Prompts for input

9.00

0.00

11 Error Messages

7.00

6.00

12 Learning to operate the system

7.00

2.00

13 Performing tasks straighforward

8.00

7.00

14 Help messages on screen

7.00

2.00

15 Supplemental reference materials

7.00

6.00

16 System speed

9.00

0.00

17 System reliability

9.00

8.00

18 Correcting your mistakes

7.00

2.00

19 Designed for all levels of users

8.00

7.00

20 I will use the system frequently

9.00

1.00

21 I felt very confident using the system

8.00

7.00

Total Possible Score (19*9 + 2+10) = 191

165.00

170.00

Questions 1-19 - scale of 1 through 9
Questions 20 & 21 - scale of 1 through 10

0.86

0.89

Table 5: DIL User Satisfaction & System Usability After DIL's Intervention - Patient 2
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Table 6: DIL User Satisfaction & System Usability
After DIL's Intervention - Patient 3
Question

Patient Response

Patient Score

1 Design

9.00

8.00

2 Difficulty

8.00

1.00

3 Usability

8.00

7.00

4 Reading Characters on Screen

9.00

0.00

5 Organization of Information

9.00

8.00

6 Sequence of Screens

8.00

1.00

7 Use of terms throughout system

9.00

8.00

8 Terminology related to task

8.00

1.00

9 Position of messages on screen

8.00

7.00

10 Prompts for input

9.00

0.00

11 Error Messages

8.00

7.00

12 Learning to operate the system

8.00

1.00

13 Performing tasks straighforward

9.00

8.00

14 Help messages on screen

8.00

1.00

15 Supplemental reference materials

8.00

7.00

16 System speed

9.00

0.00

17 System reliability

9.00

8.00

18 Correcting your mistakes

8.00

1.00

19 Designed for all levels of users

8.00

7.00

20 I will use the system frequently

10.00

0.00

21 I felt very confident using the system

10.00

9.00

Total Possible Score (19*9 + 2+10) = 191

180.00

180.00

Questions 1-19 - scale of 1 through 9
Questions 20 & 21 - scale of 1 through 10

0.94

0.94

Table 6: DIL User Satisfaction & System Usability After DIL's Intervention - Patient 3
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Table 7: DIL User Satisfaction & System Usability
After DIL's Intervention - Patient 4
Question

Patient Response

Patient Score

1 Design

8.00

7.00

2 Difficulty

8.00

1.00

3 Usability

6.00

5.00

4 Reading Characters on Screen

8.00

1.00

5 Organization of Information

8.00

7.00

6 Sequence of Screens

7.00

2.00

7 Use of terms throughout system

8.00

7.00

8 Terminology related to task

8.00

1.00

9 Position of messages on screen

8.00

7.00

10 Prompts for input

8.00

1.00

11 Error Messages

7.00

6.00

12 Learning to operate the system

8.00

1.00

13 Performing tasks straighforward

8.00

7.00

14 Help messages on screen

6.00

3.00

15 Supplemental reference materials

8.00

7.00

16 System speed

8.00

1.00

17 System reliability

6.00

5.00

18 Correcting your mistakes

6.00

3.00

19 Designed for all levels of users

6.00

5.00

20 I will use the system frequently

8.00

2.00

21 I felt very confident using the system

8.00

7.00

Total Possible Score (19*9 + 2+10) = 191

156.00

172.00

Questions 1-19 - scale of 1 through 9
Questions 20 & 21 - scale of 1 through 10

0.82

0.90

Table 7: DIL User Satisfaction & System Usability After DIL's Intervention - Patient 4

36

Table 8: DIL User Satisfaction & System Usability
After DIL's Intervention - Patient 5
Question

Patient Response

Patient Score

1 Design

9.00

8.00

2 Difficulty

8.00

1.00

3 Usability

8.00

7.00

4 Reading Characters on Screen

8.00

1.00

5 Organization of Information

8.00

7.00

6 Sequence of Screens

8.00

1.00

7 Use of terms throughout system

9.00

8.00

8 Terminology related to task

9.00

0.00

9 Position of messages on screen

8.00

7.00

10 Prompts for input

8.00

1.00

11 Error Messages

9.00

8.00

12 Learning to operate the system

9.00

0.00

13 Performing tasks straighforward

9.00

8.00

14 Help messages on screen

8.00

1.00

15 Supplemental reference materials

8.00

7.00

16 System speed

9.00

0.00

17 System reliability

9.00

8.00

18 Correcting your mistakes

8.00

1.00

19 Designed for all levels of users

8.00

7.00

20 I will use the system frequently

10.00

0.00

9.00

8.00

Total Possible Score (19*9 + 2+10) = 191

179.00

178.00

Questions 1-19 - scale of 1 through 9
Questions 20 & 21 - scale of 1 through 10

0.94

0.93

21 I felt very confident using the system

Table 8: DIL User Satisfaction & System Usability After DIL's Intervention - Patient 5
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The patients also made the following general comments about their experience with DIL.

Table 9 - General Comments by patients about their experience with DIL
1 The app is very well designed. It prompts me to monitor my health on regular basis.
2 It reminds on timely basis & keep consistency. Because of daily reminders from DIL, I make it a point to
walk for at least 20 minutes every day.
3 It would have been better if I could talk to the system.
4 Motivational messages in video format would have been more helpful.
5 Great product to help track health goals .

Table 9: Patient general feedback about DIL

4.3 FINDINGS FOR RESEARCH QUESTION 2
The researcher used two instruments to answer Research question 2. First, Health dashboard results from before and after DIL's
intervention were compared to see potential improvements in health and behavioral outcomes. Second, data from the "Minnesota
Living with Heart Failure" questionnaire were compared to determine the patients' quality of life.

DESCRIPTIVE STATIS TICS - HEALTH DASHBOARD RESULTS
For health dashboard results, the researcher compared before and after means of the following vitals:

• Weight
• Systolic Blood Pressure
• Diastolic Blood Pressure
• Pulse
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WEIGHT
Table 10 shows the mean values and the paired t-test result for Weight for the 5 patients.

Table 10: Comparison of Mean Values of Weight before and during DIL's Intervention
Mean Weight Before

Mean Weight During

Difference of the

DIL's Intervention

DIL's Intervention

Means - D

D2

Patient 1

164.60

151.00

13.60

184.96

Patient 2

197.90

189.47

8.43

71.12

Patient 3

185.56

185.71

-0.15

0.02

Patient 4

129.29

128.31

0.98

0.96

Patient 5

190.57

190.82

-0.25

0.06

∑ = 22.61

∑ = 257.12

2.776

p=0.05

173.58

169.06

27.69

28.08

766.48

788.39

N

5

5

Df

4

4

1.63

t-critical =

μ
SD
Variance

t-value =

Table 10: Comparison of Mean Values of Weight before and during DIL's Intervention
For patients with heart failure, it is absolutely critical to take medications on time, get some form exercise on a daily basis, and
eat healthy. Monitoring weight multiple times a week to look for abnormal fluctuations in weight is extremely important. The
researcher monitored and compared mean weight of the patients for two weeks before DIL's intervention with the mean weight of
the patients during DIL's intervention for 4 weeks. A paired t-test was conducted by comparing the mean weights; although there
is a slight drop in the mean weight of the patients (µ), it was found to be not statistically significant (t=value = 1.63, p=0.05).
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SYSTOLIC BLOOD PRESSURE
Table 11 shows the mean values and the paired t-test result for Systolic Blood Pressure for the 5 patients.

Table 11: Comparison of Mean Values of Systolic Blood Pressure before and during DIL's Intervention
Mean Systolic BP Before Mean Systolic BP During
DIL's Intervention

DIL's Intervention

Difference of the

D2

Means - D

Patient 1

113.10

120.77

-7.67

58.82

Patient 2

156.30

146.73

9.57

91.52

Patient 3

132.00

135.06

-3.06

9.36

Patient 4

125.56

137.72

-12.17

148.03

Patient 5

134.71

124.73

9.99

99.74

∑ = -3.34

∑ = 407.46

2.776

p=0.05

132.33

133.00

15.78

10.41

249.01

108.29

N

5

5

Df

4

4

-0.15

t-critical =

μ
SD
Variance

t-value =

Table 11: Comparison of Mean Values of Systolic Blood Pressure before and during DIL's Intervention
As in weight, the systolic Blood pressure is also an important vital to monitor multiple times a week as fluctuations beyond a
normal range can be an indicator that something is not right. Systolic Blood Pressure readings were monitored for two weeks
before DIL's intervention, and for four weeks during DIL's intervention. The mean values were compared, and a paired t-test was
conducted. The mean values (µ) were virtually unchanged, and was not statistically significant (t-value=-0.15, p=0.05).
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DIASTOLIC BLOOD PRESSURE
Table 12 shows the mean values and the paired t-test result for Diastolic Blood Pressure for the 5 patients.

Table 12: Comparison of Mean Values of Diastolic Blood Pressure before and during DIL's Intervention
Mean Diastolic BP

Mean Diastolic BP

Difference of the

Before DIL's

During DIL's

Means - D

Intervention

Intervention

D2

Patient 1

73.50

71.15

2.35

5.50

Patient 2

65.60

62.53

3.07

9.40

Patient 3

86.89

84.24

2.65

7.04

Patient 4

83.11

90.39

-7.28

52.97

Patient 5

86.00

80.64

5.36

28.77

∑ = 6.15

∑ = 103.69

2.776

p=0.05

79.02

77.79

9.19

11.01

84.49

121.30

N

5.00

5.00

Df

4

4

0.56

t-critical =

μ
SD
Variance

t-value =

Table 12: Comparison of Mean Values of Diastolic Blood Pressure before and during DIL's Intervention
Like Systolic Blood Pressure, Diastolic Blood Pressure was also measured multiple times a week. Diastolic Blood pressure
readings were taken for two weeks before DIL's intervention, and for four weeks during DIL's intervention. The mean values
were compared, and a paired t-test was conducted. The mean values (µ) were virtually unchanged, and was not statistically
significant (t-value=0.56, p=0.05).
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PULSE
Table 13 shows the mean values and the paired t-test result for Pulse readings for the 5 patients.

Table 13: Comparison of Mean Values of Pulse before and during DIL's Intervention
Mean Weight Before

Mean Weight During

Difference of the

DIL's Intervention

DIL's Intervention

Means - D

D2

Patient 1

68.40

64.62

3.78

14.32

Patient 2

68.30

61.60

6.70

44.89

Patient 3

80.00

74.65

5.35

28.65

Patient 4

88.89

91.22

-2.33

5.44

Patient 5

56.29

59.45

-3.17

10.04

∑ = 10.34

∑ = 103.35

2.776

p=0.05

μ

72.37

70.31

SD

12.47

13.06

155.53

170.57

N

5.00

5.00

Df

4

4

1.02

t-critical =

Variance

t-value =

Table 13: Comparison of Mean Values of Pulse before and during DIL's Intervention
Pulse readings are also an important vital to monitor on a regular basis as abnormal heart beat can be a sign of worry. The
patients' pulse readings were recorded multiple times a week for two weeks before DIL's intervention and for four weeks during
DIL's intervention; the mean values were compared and found to be almost unchanged. A paired t-test result of the means showed
no statistical significance (t-value=1.02, p=0.05).
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DESCRIPTIVE STATISTICS - QUALIT Y

OF

LIFE

The "Minnesota Living with Heart Failure" questionnaire was used before and after DIL's intervention to gauge improvements in
Health outcomes and Quality of Life of the patients. The questionnaire is comprised of 21 important physical, emotional and
socioeconomic ways heart failure can adversely affect a patient’s life. After receiving brief standardized instructions, the patient
marked a 0 (zero) to 5 scale to indicate how much each itemized adverse of heart failure has prevented the patient from living as
he or she wanted to live during the past 4 weeks. The questionnaire is simply scored by summation of all 21 responses.

This patient-reported outcome can be used to determine whether a treatment for heart failure is effective for improving patients’
quality of life by reducing the adverse impact of heart failure.

Table 14 summarizes the findings before DIL's intervention. Table 15 shows the results for the same questionnaire taken by the
patients after the trial period.
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Table 14: Minnesota Living with Heart Failure Questionnaire - Before DIL's Intervention
Did your heart failure prevent
you from living as you wanted during the

Patient Patient Patient Patient Patient Mean
1

2

3

4

SD

Variance

5

past month (4 weeks) by 1 causing swelling in your ankles or legs?

0

3

0

0

0

0.6 1.34

1.80

2 making you sit or lie down to rest during the day?

0

3

4

3

4

2.8 1.64

2.70

3 making your walking about or climbing stairs
difficult?

0

4

3

4

4

3 1.73

3.00

4 making your working around the house or yard
difficult?

0

5

3

4

3

3 1.87

3.50

5 making your going places away from home
difficult?

1

5

4

3

4

3.4 1.52

2.30

6 making your sleeping well at night difficult?

2

5

4

2

3

3.2 1.30

1.70

7 making your relating to or doing things with your
friends or family difficult?

1

5

3

4

3

3.2 1.48

2.20

8 making your working to earn a living difficult?

2

5

3

5

4

3.8 1.30

1.70

9 making your recreational pastimes, sports or
hobbies difficult?

2

5

3

5

4

3.8 1.30

1.70

10 making your sexual activities difficult?

0

5

4

4

4

3.4 1.95

3.80

11 making you eat less of the foods you ilke?

3

5

4

5

5

4.4 0.89

0.80

12 making you short of breath?

3

5

1

3

4

3.2 1.48

2.20

13 making you tired, fatigued, or low on energy?

4

5

5

3

4

4.2 0.84

0.70

14 making you stay in hospital?

0

0

0

2

3

1 1.41

2.00

15 costing you money for medical care?

5

5

3

5

4

4.4 0.89

0.80

16 giving you side effects from treatment?

1

5

4

4

4

3.6 1.52

2.30

17 making you feel you are a burdento your family or
friends?

4

0

1

4

3

2.4 1.82

3.30

18 making you feel a loss of self control in your life?

4

5

3

4

5

4.2 0.84

0.70

19 making you worry?

4

5

3

4

5

4.2 0.84

0.70

20 making it difficult to you to concentrate or
remember things?

4

5

4

3

4

4 0.71

0.50

21 making you feel depressed?

4

3

4

4

4

3.8 0.45

0.20

44

88

63

75

78

TOTAL

69.6

Table 14: Minnesota Living with Heart Failure Questionnaire - Before DIL's Intervention
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Table 15: Minnesota Living with Heart Failure Questionnaire - After DIL's Intervention
Did your heart failure prevent
you from living as you wanted during the

Patient Patient Patient Patient Patient Mean
1

2

3

4

SD

Variance

5

past month (4 weeks) by 1 causing swelling in your ankles or legs?

0

3

0

0

0

0.60 1.34

1.80

2 making you sit or lie down to rest during the day?

0

3

4

3

4

2.80 1.64

2.70

3 making your walking about or climbing stairs
difficult?

0

4

3

3

4

2.80 1.64

2.70

4 making your working around the house or yard
difficult?

0

5

3

4

3

3.00 1.87

3.50

5 making your going places away from home
difficult?

1

4

3

3

3

2.80 1.10

1.20

6 making your sleeping well at night difficult?

1

4

3

2

3

2.60 1.14

1.30

7 making your relating to or doing things with your
friends or family difficult?

1

5

2

3

3

2.80 1.48

2.20

8 making your working to earn a living difficult?

2

5

2

4

4

3.40 1.34

1.80

9 making your recreational pastimes, sports or
hobbies difficult?

1

4

2

4

4

3.00 1.41

2.00

10 making your sexual activities difficult?

0

5

3

4

4

3.20 1.92

3.70

11 making you eat less of the foods you ilke?

3

5

4

5

5

4.40 0.89

0.80

12 making you short of breath?

2

5

1

3

4

3.00 1.58

2.50

13 making you tired, fatigued, or low on energy?

3

4

4

2

4

3.40 0.89

0.80

14 making you stay in hospital?

0

0

0

0

0

0.00 0.00

0.00

15 costing you money for medical care?

4

5

3

4

4

4.00 0.71

0.50

16 giving you side effects from treatment?

1

4

3

4

3

3.00 1.22

1.50

17 making you feel you are a burdento your family or
friends?

3

0

0

3

3

1.80 1.64

2.70

18 making you feel a loss of self control in your life?

3

4

2

4

5

3.60 1.14

1.30

19 making you worry?

3

5

2

4

5

3.80 1.30

1.70

20 making it difficult to you to concentrate or
remember things?

3

5

4

3

4

3.80 0.84

0.70

21 making you feel depressed?

3

3

4

3

4

3.40 0.55

0.30

34

82

52

65

73

TOTAL

61.2

Table 15: Minnesota Living with Heart Failure Questionnaire - After DIL's Intervention
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Figure 18 shows the change in the Mean score for the patients.

80

70

60

MLHFQ - Before
Mean = 69.6
MLHFQ - After
Mean = 61.2

50

40

30

20

10

0
MLHFQ - Mean Before and Afte r

Figure 18: Change in Mean Score - Minnesota Living with Heart Failure Questionnaire - Before and After
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4.4 FINDINGS FOR RESEARCH QUESTION 3
A qualitative survey, "Perceived Helpfulness of DIL" (see Appendix C) was used to gather the Patients' experience interacting
with DIL. Did the patients find DIL helpful to keep them motivated, and help in better adherence to clinical guidelines like taking
medications on time, controlling their diet, and exercise were important criteria to determine if DIL can complement a human
case worker like a nurse or a clinician.

The following figures show the patients' responses to this qualitative survey:

RESPONSE
DIL?

TO

QUESTION 1 - OVERALL HOW HELPFUL

OR

UNHELPFUL

WA S

Overall how helpful or unhelpful was DIL?
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Extremely helpful

Moderately helpful

Slightly helpful

Neither helpful nor
unhelpful

Slightly unhelpful

Moderately
unhelpful

Extremely
unhelpful

Figure 19: Patient response to "Overall how helpful or unhelpful was DIL?"
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Table 16 shows the distribution.

#

Answer
1

Extremely helpful

2

%

Count
100.00%

5

Moderately helpful

0.00%

0

3

Slightly helpful

0.00%

0

4

Neither helpful nor unhelpful

0.00%

0

5

Slightly unhelpful

0.00%

0

6

Moderately unhelpful

0.00%

0

7

Extremely unhelpful

0.00%

0

100%

5

Total

Table 16: Patient response to "Overall how helpful or unhelpful was DIL?"
When asked about the helpfulness of DIL in motivating them to stay the course - taking medications on time, controlling their
diet and exercise, all five patients responded that they found DIL extremely helpful.

RESPONSE

TO QUESTION

2: WAS CONVERSING

WITH

DIL EASY

Was conversing with DIL easy?
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Extremely easy

Moderately easy

Slightly easy

Neither easy nor
difficult

Slightly difficult

Moderately difficult

Extremely difficult

Figure 20: Patient response to "Was conversing with DIL easy?"
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Table 17 shows the distribution.

#

Answer

%

Count

1

Extremely easy

80.00%

4

2

Moderately easy

20.00%

1

3

Slightly easy

0.00%

0

4

Neither easy nor difficult

0.00%

0

5

Slightly difficult

0.00%

0

6

Moderately difficult

0.00%

0

7

Extremely difficult

0.00%

0

100%

5

Total

Table 17: Patient response to "Was Conversing with DIL easy?"
In response to the question about conversing with a chatbot like DIL, 4 out of the 5 patients (80%) found it to be extremely easy,
and 1 patient, the oldest patient at 70+ years of age (20%) found it to be moderately easy.

RESPONSE
USEFUL?"

TO

QUESTION 3: "WERE

THE

M OT I VAT I O N A L M E S SAG E S

Were the Motivational messages useful?

80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Extremely useful

Very useful

Moderately useful

Slightly useful

Not useful at all

Figure 21: Patient response to "Were the motivational messages useful?
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Table 18 shows the distribution.

#

Answer

%

Count

1

Extremely useful

20.00%

1

2

Very useful

80.00%

4

3

Moderately useful

0.00%

0

4

Slightly useful

0.00%

0

5

Not useful at all

0.00%

0

100%

5

Total

Table 18: Patient response to "Were the motivational messages useful?"
With regard to the motivational messages, 1 patient (20%) found them to be "extremely useful", the other 4 (80%) found them to
be "very useful". As a general feedback on the User satisfaction and usability survey (Table 9), one patient actually said that
motivational messages in video format would have been more helpful. It is an area that definitely needs further consideration.

RESPONSE

TO

QUESTION 4: HOW

HELPFUL OR UNHELPFUL WERE THE LINKS

TO VA R I O U S P U B L I S H E D A RT I C L E S O N R E L E VA N T TO P I C S ?

How helpful or unhelpful were the ink to the articles?
60.00%

50.00%

40.00%

30.00%

20.00%

10.00%

0.00%
Extremely helpful

Moderately helpful

Slightly helpful

Neither helpful nor
unhelpful

Slightly unhelpful

Moderately
unhelpful

Extremely
unhelpful

Figure 22: Patient response to "How helpful or unhelpful were the links to articles?"
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Table 19 shows the distribution.

#

Answer

%

Count

1

Extremely helpful

60.00%

3

2

Moderately helpful

40.00%

2

3

Slightly helpful

0.00%

0

4

Neither helpful nor unhelpful

0.00%

0

5

Slightly unhelpful

0.00%

0

6

Moderately unhelpful

0.00%

0

7

Extremely unhelpful

0.00%

0

100%

5

Total

Table 19: Patient response to "How helpful or unhelpful were the links to articles?"
In order to motivate patients to do better, DIL often referred the patients to relevant health articles in leading journals freely
available on the web. Three patients (60%) found these articles to be "Extremely helpful", and two patients (40%) found them to
be "Moderately helpful."

RESPONSE

TO

QUESTION 5: "DID DIL

HELP YOU IN IMPROVING YOUR

LIFEST YLE AND ADHERENCE TO CLINICAL GUIDELINES?"

Did DIL help you in improving your lifestyle and adherence to clinical guidelines?
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Extremely helpful

Moderately helpful

Slightly helpful

Neither helpful nor
unhelpful

Slightly unhelpful

Moderately
unhelpful

Extremely
unhelpful

Figure 23: Patient response to "Did DIL help you in improving your lifestyle and adherence to clinical guidelines?"
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Table 20 shows the distribution.

#

Answer
1

Extremely helpful

2

%

Count
100.00%

5

Moderately helpful

0.00%

0

3

Slightly helpful

0.00%

0

4

Neither helpful nor unhelpful

0.00%

0

5

Slightly unhelpful

0.00%

0

6

Moderately unhelpful

0.00%

0

7

Extremely unhelpful

0.00%

0

100%

5

Total

Table 20: Patient response to "Did DIL help you in improving your lifestyle and adherence to clinical guidelines?"
Finally when the patients were asked about DIL's role in helping them improve their lifestyle and adherence to clinical
guidelines, all five patients (100%) found DIL to be "Extremely helpful." This finding was confirmed again when the mean
scores of the Minnesota Living with Heart failure questionnaire from before and after DIL's intervention were compared; it
showed a significant improvement (figure 16).
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CHAPTER 5: DISCUSSION
Chapter 5 consists of three sections. First is a summary of the research problem, the research methods used in the study, and the
data analysis. The second section consists of the research findings, conclusions, and implications for further practice. The third
section and conclusion to the chapter will include recommendations for further research.

5 .1 S U M M A R Y O F R E S E A R C H P R O B L E M S A N D R E S E A R C H
METHODS
Chronic conditions are increasingly impacting life expectancy and the cost of healthcare all over the world. Among these
conditions, Cardiovascular Disease (CVD) stands out because its prevalence continues to rise. Congestive Heart Failure (CHF) is
the most common Medicare diagnosis. In 2012, the American Heart Association reported that 1 out of 5 of individuals with CHF
dies within a year of diagnosis [2]. According to 2018 report the estimated annual incidence of heart attack in the US is 720,000
new attacks and 335,000 recurrent attacks. Average age at the first heart attack is 65.6 years for males and 72.0 years for females.
Approximately every 40 seconds, an American will have a heart attack [1].

CHF also incurs the highest cost for diagnosis and treatment. A 2009 report estimated these costs to be around 37.2 billion dollars
[1]. 21.2% of Medicare patients diagnosed with CHF were readmitted to the hospital within 30 days of discharge [1]. A 2018
report estimated direct and indirect cost of heart disease in 2013 to 2014 (average annual) was $204.8 billion. Heart attacks
($12.1 billion) and Coronary Heart Disease ($9.0 billion) were 2 of the 10 most expensive conditions treated in US hospitals in
2013. Between 2013 and 2030, medical costs of Coronary Heart Disease are projected to increase by about 100 percent.

The cost of these readmissions exceeded $15 billion per year (MedCAP) [1]. As readmissions continued, the Center for Medicare
and Medicaid Services (CMS) decided to penalize hospitals with high CHF readmission rates by not reimbursing them for the
services they provide since prior studies show that CHF hospital readmissions could be reduced with quality outpatient services
and adherence to care.

As patients move into their home setting when discharged from the hospitals there is a discontinuity in care services that these
highly vulnerable patients need. The high readmission rates for heart failure cases have often been attributed to the lack of
effective strategies to support the transition in care from the hospital to the home environment.

53

In spite of best intentions, and effort, it is simply not possible for the caregiver community to reach out to each and every patient
in their homes and follow up with them. There are simply too many patients and not enough nurses, clinicians, and doctors. The
problem in essence is that human support simply cannot scale to meet the growing needs of a rising elderly population who are
living with Heart Failure.

The purpose of this study was to evaluate the artifact, DIL, a conversational agent for heart-failure patients. The researcher was
particularly interested to find out if DIL can elicit behavior change, a change in quality of life, and better adherence to clinical
guidelines for the patients in the study group.

The research questions guiding the study were broadly divided into two main categories - Human-computer interaction, and
Complimenting the Care-giver community. The questions were:

1. How much engagement can DIL elicit?
2. Can DIL be as persuasive as a human health care worker?
3. Can an Assistive Technology like DIL lower the Caregiver burden in scaling with a large population?

Five heart-failure patients in their home setting participated in this study. They were each given a set of home monitoring devices
like bluetooth enabled weight scale, blood pressure and pulse monitor, and a tablet with MyHeart app installed [32]. The patients
were asked to measure weight, blood pressure and pulse, and answer symptomatic questions if possible everyday during the study
period. The measurements were uploaded automatically to the Home minoring dashboard (figure 7). The patients were monitored
for two weeks prior to DIL's intervention and for a further four weeks during DIL's intervention. The patients completed the
Minnesota Living with Heart failure questionnaire before and after the study. They also participated in two other surveys - a
survey on the Perceived Helpfulness of DIL, and a User satisfaction and System Usability survey (see appendix). Quantitative
data from the home monitoring dashboard were compared from before and during DIL's intervention, and descriptive statistical
analysis were performed to determine any noticeable improvement health outcome measurements.
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5.2 S TUDY CONCLUSIONS
CONCLUSIONS

FOR

RESEARCH QUESTION 1

To answer the question about the engagement DIL can elicit, two different measures were used. First the user engagement was
measured, and then quantitative data was used to measure the User satisfaction and their feedback on System usability.

Figure 15, 16 & 17 shows the User engagement over the trial period, and indicated a better than expected user participation. DIL
sent messages every day for four weeks, and patients responded multiple times a week to converse with DIL, and discuss the data
recorded by the Home monitoring devices. The patient engagement was extremely good with a mean engagement percentage of
62.14%. The patients also spent considerable time chatting with DIL with a mean chat duration at 18 minutes.

The quantitative data as measured by the User Satisfaction and System Usability survey indicated an average score of almost 90
for every patient (see tables 4 through 8). This means that the patients were highly satisfied with the functionality of the system,
and would not only use the system again, but also recommend to friends and family.

Overall conclusion to Research Question 1 is extremely positive; it can be safely said that DIL scored high on User engagement
and satisfaction, which is also confirmed by the General Feedback and Comments as shown on Table 9. Comments like "The app
is very well designed. It prompts me to monitor my health on regular basis", "It reminds on timely basis & keep consistency" and
"Great product to help track health goals" only reinforces the positive user experience. This is probably also the reason for high
engagement between DIL and the patients because when users' experiences with a technology artifact is positive, they are more
likely to use the system.

CONCLUSIONS

FOR

RESEARCH QUESTION 2

Research question 2 was perhaps the most important question of the study - if DIL can be as persuasive to positively change and
reinforce a patient's behavior as a human caregiver normally would. The researcher used quantitative and qualitative data to
answer this question.

First, the Health dashboard measurements were compared from two weeks prior to DIL's intervention to four weeks during DIL's
intervention. In particular, vital health parameters like fluctuations in weight, systolic and diastolic blood pressure, and pulse
readings were compared. The mean scores for the five patients from before and during DIL's intervention were compared, and a
paired t-test within the group was performed for a p-value of 0.05.

Table 21 summarizes the findings.
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Table 21: t-value, t-ctitical and p-value for Vital Health Parameters
T-value

T-critical

P-value

Statistical Significance

Weight

1.63

2.776

0.05

Not significant

Systolic Blood Pressure

-0.15

2.776

0.05

Not significant

Diastolic Blood Pressure

0.56

2.776

0.05

Not significant

Pulse

1.02

2.776

0.05

Not significant

n=5

df=4

Table 21: t-value, t-critical and p-value for Vital Health Parameters
None of the health parameters that were measured showed any significant statistical change due to DIL's intervention. While at
first, this might look discouraging for this research, but it is actually not a bad thing. The study duration was short - a total of six
weeks, two weeks before DIL's intervention, and four weeks during DIL's intervention. A significant fluctuation is not desirable
during such a short duration as any such change will be a cause of concern and would be considered a high-risk. All the five
patients had good family support, are well educated, and understand how to manage a chronic disease like heart failure better
than the average population to begin with. In essence they were adhering to clinical guidelines like taking medications in a timely
manner, controlling their diet and exercising on a regular basis. Given this scenario, the slight improvements in the mean values
for all the four health parameters that were measured was actually an excellent health and behavioral outcome.

The second instrument used to answer Research question 2, was the qualitative survey - Minnesota living with Heart Failure
questionnaire (MLHFQ). The patients took the survey at the beginning of the trial, and again at the conclusion of the trial, and the
results are extremely encouraging (see tables 14 and 15, and figure 17). There are twenty one questions on this survey that can be
divided up into two broad categories - physical and emotional domain. Questions 1-7, 12 and 13 ask questions about physical
limitations, and fall under the Physical domain. Questions 17-21 ask questions mainly about the patients' emotional state, and fall
under the emotional domain [55]. The patients respond to each question on a Likert scale of 0-5, and the total score is calculated
by adding up the response to each question. The mean score of each of the patients' total scores from before the trial was
compared to the mean score from after the trial. As shown in Figure 17, the mean scores showed significant improvement (Mean
before = 69.6, and Mean after = 61.2). A change of 4 in the Mean score is considered significant.

Overall conclusion to Research question 2 is mixed at worst, and positive at best. The health dashboard results - changes in
weight, blood pressure and pulse readings, although not statistically significant showed slight improvements. None of the patients
showed any decline on their health and behavioral outcomes during the trial period, and none needed clinical intervention during
the trial period. On the quality of life survey, every patient felt significantly more positive on both physical and emotional domain
questions, and had a positive outlook on their quality of life going forward. Monitoring their critical health data on a regular
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basis, and positive reinforcements from DIL motivated them to do better and continue to lead a healthy lifestyle. One patient said,
"...because of daily reminders from DIL, I make it a point to walk at least 20 minutes every day."

CONCLUSIONS

TO

RESEARCH QUESTION 3

The researcher used a Qualitative survey, "Perceived Helpfulness of DIL" to answer research questions 3 and 4. The survey
results are shown in Figures 18 through 22 and Tables 16 through 20. The findings indicate an extremely positive feedback from
the patients on DIL's helpfulness on their quality of life and achieving a better health and behavioral outcome. Each of the five
patients gave an "extremely positive" to "mostly positive" response to this five-question survey.

Because the results of this study are exceptionally positive and the participants in this study had never used an IT artifact like DIL
before, there is a possibility of a “novelty effect” leading to patient approval. The novelty effect is a common reactive-effect
which can threaten external validity. The novelty effect refers to the success of a treatment because it is new and different.
Lodico, Spaulding, and Voegtle (2006) [56] wrote, “After a while, the novelty wears off and the new treatment is no better than
the old treatment” (p. 199). In essence, “the novelty effect means that a treatment is effective only when it is new and novel and
that the treatment’s effectiveness will not generalize beyond this initial period of time” (p. 199).

Although it is possible the novelty effect may have caused the extremely positive results, this is unlikely due to several reasons.
First, all the patients in the study are well educated and well versed in modern technology. They were all very familiar with social
media technologies like Facebook and Facebook Messenger, and other web 2.0 technologies, and are active participants on social
media. Second, although the patients have not encountered a conversational agent like DIL for chronic disease management
before, they were familiar with chat-bots. So the technology in itself was not totally new.

Overall conclusion to Research question 3 is positive; given the extremely positive experience of the patients, there is definitely
room for such an IT artifact in supporting patients as they make the transition from hospital to the home setting. Although it can
be argued that the patient population in the trial was small and did not adequately represent the patient population with Heart
Failure at large, and further exploration is definitely required, the early results indicate that DIL can play a role in alleviating the
caregiver burden.
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5.3 SCOPE AND LIMITATIONS
SETTING

AND

SAMPLE SIZE

Generalizability of findings is one of the potential limitations of this study because:

•

The sample size is small (n=5 for patients) and participants could refuse to continue with the study, experience
deterioration in health, or even pass away.

However, Nielson & Lauder [43] argue that 3-5 participants is a sufficient sample size to test the usability of a system. Further, it
is expected that the research will motivate future research to replicate the artifact and test the design in other healthcare contexts.

CONTROL

AND

VALIDITY

Given that the evaluation uses a field experiment and there is a lack of control over variables in the environment, the validity of
findings might be questionable because the variables of interest are not measured accurately. For example, seasonal effects might
influence the number of hospitalizations in heart failure patients as changes in weather and flu season are correlated to higher
admission rates. Thus, the results could be biased.

RESOURCES
It is anticipated that interviewing clinicians and patients will be challenging due to the limited time they have.

TECHNOLOGY

BARRIERS

Learning how to use a new technology and adapting to it is not a trivial task especially since participants will be involved in the
first iterations of designing and testing the application. Technical issues such as, software bugs, connectivity issues, or locked
mobile phones are real problems that must be addressed and dealt with as and when they arise.
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5.4 RESEARC H IMPLIC ATIONS
The data gathered during the research and its analysis, especially the findings with respect to the research questions paints an
extremely positive picture for an IT artifact like DIL. As mentioned in Chapter 1, with proper disease management, early
symptoms of disease exacerbation could be detected and treatments could be initiated to prevent them [3], lowering the risk of
deteriorating quality of life, death, or readmission to the hospital. Therefore, the American Heart Association recommends patient
education and close monitoring to improve treatment adherence [6]. Because of the large number of people living with Heart
Failure, and because it is simply not possible to reach out and address the growing needs of patients, an alternative strategy, an IT
artifact like DIL is the need of the hour. This study validates DIL as a useful tool that can potentially fill in the gap.

The study was limited in the sense that the patient group was small and not diverse enough, so a study with a larger patient
population with a greater degree of variety in terms of ethnicity, financial background, and age groups representing all strata of
the society, will be ideal. The study period was small (only six weeks). To really evaluate the potential and capability of an IT
artifact like DIL, a longer term trial of three months to six months would have been ideal, but such a lengthy study was beyond
the scope of this dissertation.

Further research is definitely needed, but the findings of this study indicates that conversational agents like DIL can play an
important role in chronic disease self-management.

CONTRIBUTIONS

TO THE FIELD OF IS&T

The research used Design Science Research principles. The primary contribution is the The artifact: DIL - a Conversational Agent
for individuals with Heart Failure; a chatbot that combines expert opinions with theories from healthcare, psychology, and
technology. Although Conversational Agents are not new, the specific application of such a system to work with Heart Failure
patients is new. This type of system was not found to exist at the beginning of this research project.

This research can also inform the design of future Conversational Agent systems and bring awareness of strategies to develop
better customized interventions. Because these strategies will be discovered in a natural setting, they will be feasible and could
form a foundation to develop guidelines for efficient self- management.

CONTRIBUTIONS

TO THE FIELD OF

PRACTICE

AND

HEART FAILURE

This research will hopefully empower and motivate patients and facilitate better communication among patients and clinicians.
Communication is key to improving health outcomes and reducing readmissions. The artifact DIL is a direct attempt to address
the Resource Problem, specifically overloading and shortage of staff issue. All conversations between DIL and an individual
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patient is recorded for further review by a knowledgeable healthcare worker like a Doctor, nurse or a clinician. These recordings
can provide valuable insight about a patient's health, her adherence to clinical guidelines, and eventually progress towards better
health and lifestyle.

CONTRIBUTION

TO

THEORY

AND

KNOWLEDGE

Due to lack of sufficient resources in the caregiver community, lack of understanding of clinical guidelines and best practices,
and lack of motivation, a significantly large number of patients fall through the crack and do not receive the support they need,
and are at high risk, despite best efforts from the care givers. So, the problem is definitely mature enough that demands a mature
solution and intervention, and as outlined in previous sections is an ideal scenario for an IT artifact like DIL.

Figure 24 shows the DSR-Knowledge Contribution Framework [62].

Figure 24: Overlaying the IT artifact DIL on the Knowledge Contribution Framework [62]
Gregor and Hevner [62] developed a 2x2 contribution framework. The framework positions contribution based on the maturity
level of the solution and application domain. As shown in Figure 23, there are four types of contributions: Routine Design,
Exaptation, Improvement, and Invention.

DIL is a Conversational Agent specifically designed for Heart Failure patients with the primary objective of complementing the
caregiver community who are over-burdened and under-staffed; assisting patients in self care and management of their chronic
condition, motivating them to adopt better behavior and a healthy lifestyle, and eventually achieving better health outcomes.
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A Conversational Agent based intervention is not new. Research has shown large success in achieving behavioral change with
this kind of approach, and has previously been tried in a variety of settings from Alcohol consumption [25], promoting health
behavior change in heart attacks [26], psychosocial intervention deployed on hand-held computers [27], hospital discharge nurse
that explains written hospital discharge instructions to patients with low health literacy [23], psychotherapy [28], and as health
dialog systems [29].

DIL borrows ideas and best practices from previously tried and tested applications in different settings, and aims to design and
implement a Conversational Agent in the specific domain of Heart Failure patients that has not been tried before. In this regard,
the IT artifact DIL falls in the Exaptation quadrant of the Knowledge Contribution Framework [62].
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5.5 FUTURE RESEARCH
Although the study was well received by the patients participating in the trial, and the findings were encouraging, there is surely
room for improvement. As mentioned in Chapter 3 the study went through multiple iterations of Design and Build. The initial
idea was to develop a voice-enabled bot, which was later discarded, as the performance of voice bots in the first prototype never
achieved the minimum threshold of acceptable quality. This is definitely an area that needs further investigation and duediligence because the future is most certainly voice where patients can talk to an artifact like DIL instead of chat.

Another limitation of the study was the short duration of only six weeks. A future random control trial with a minimum of ten
patients over three to six months will be ideal to really gauge the impact of DIL on behavior and health outcomes - an
improvement on all health vitals like weight, blood pressure and other symptoms will really validate the efficacy of a
conversational agent like DIL. If possible, the trial should include two groups of patients - the first group will receive support
from nurses and clinicians, and the second group will be supported by DIL. At the end of the trial health and behavioral outcomes
can be compared to measure the effectiveness of DIL.

Further an integration with IBM Watson - a rule based expert system that can accurately predict the recurrence of heart failure by
monitoring a patient's individual responses during conversation with DIL and his or her health dashboard results will go a long
way in addressing the resource problem mentioned in earlier sections. A more in depth data analysis of patient's responses and
dashboard results using machine learning and artificial intelligence will make DIL smarter, and further customize and tailor
conversations based on every patient's individual needs.

Finally the current artifact was limited to home monitoring dashboard results. In an ideal scenario, DIL will not only review these
dashboard results, but further integrate with the patients' electronic health records residing in the primary care physician's office,
and take advantage of the rich repository of patient health information. DIL can then mine that data, and provide a more
comprehensive picture of the patients' health, and develop the capability to truly converse with patients using Natural Language
Processing (NLP) in an intelligent way. DIL can also proactively notify the doctors, nurses and members of the caregiver
community when it identifies patients with high risk, so that the doctors and the nurses can follow up with patients before
something goes wrong.

As technology continues to mature, with machine learning and artificial intelligence, and other Personal Healthcare devices
become an everyday part of human life, a voice-enabled Health assistant that is smarter and can review not only the homemonitoring health data but a patient's complete medical history, something along the likes of Siri, Alexa, Cortana or Google
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Assistant is what the patients will demand. Such a system can not only cater to Heart Failure patients but all patients with chronic
conditions.
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APPENDIX
A P P E N D I X A - D I L - Q U E S T I O N N A I R E F O R U S E R I N T E R FAC E
SAT I S FAC T I O N

Start of Block: OVERALL REACTION TO SOFTWARE
Q1 Design
Terrible
0

1

2

3

Wonderful
4

5

5

6

7

8

9

8

9

8

9

()

Q2 Difficulty
Difficult
0

1

2

3

Easy
4

5

5

6

7

()

Q3 Usability
Frustrating
0

1

2

3

Satisfying
4

5

5

6

7

()

End of Block: OVERALL REACTION TO SOFTWARE
Start of Block: SCREEN
Q4 Reading characters on screen
Hard

Easy
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0

1

2

3

4

5

5

6

7

8

9

()

Q5 Organization of information
Confusing
0

1

2

3

Very Clear
4

5

5

6

7

8

9

()

Q6 Sequence of screens
Confusing
0

1

2

3

Very Clear
4

5

5

6

7

8

9

()

End of Block: SCREEN
Start of Block: TERMINOLOGY AND SYSTEM INFORMATION
Q7 Use of terms throughout system
Inconsistent
0

1

2

3

Consistent
4

5

5

6

7

8

9

8

9

()

Q8 Terminology related to task
Never
0

1

2

3

Always
4

5

5

6

7

()
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Q9 Position of messages on screen
Inconsistent
0

1

2

3

Consistent
4

5

5

6

7

8

9

8

9

8

9

8

9

8

9

()

Q10 Prompts for input
Confusing
0

1

2

3

Clear
4

5

5

6

7

()

Q11 Error Messages
Unhelpful
0

1

2

3

Helpful
4

5

5

6

7

()

End of Block: TERMINOLOGY AND SYSTEM INFORMATION
Start of Block: LEARNING
Q12 Learning to operate the system
Difficult
0

1

2

3

Easy
4

5

5

6

7

()

Q13 Performing tasks is straightforward
Never
0

1

2

3

Always
4

5

5

6

7

()
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Q14 Help messages on the screen
Unhelpful
0

1

2

3

Helpful
4

5

5

6

7

8

9

8

9

()

Q15 Supplemental reference materials
Confusing
0

1

2

3

Clear
4

5

5

6

7

()

End of Block: LEARNING
Start of Block: SYSTEM CAPABILITIES
Q16 System speed
Too slow
0

1

2

3

Fast enough
4

5
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6

7

8

9

8

9

8

9

()

Q17 System reliability
Unreliable
0

1

2

3

Reliable
4

5

5

6

7

()

Q18 Correcting your mistakes
Difficult
0

1

2

3

Easy
4

5

5

6

7

()

73

Q19 Designed for all levels of users
Never
0

1

2

3

Always
4

5

5

6

7

8

9

()

End of Block: SYSTEM CAPABILITIES
Start of Block: GENERAL FEEDBACK
Q20 I will use the system frequently
Strongly Disagree
0

1

2

3

4

Strongly Agree
5

6

7

8

9

10

1 ()

Q21 I felt very confident using the system
Strongly Disagree
0

1

2

3

4

Strongly Agree
5

6

7

8

9

10

()

Q22 Other Comments
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
End of Block: GENERAL FEEDBACK
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APPENDIX B - DIL-PERCEIVED HELPFULNESS

Start of Block: SURVEY INSTRUCTIONS
Welcome Message
Welcome! The purpose of this survey is find the effectiveness of DIL in helping you lead your life better in your own home
setting.
Please answer all questions to the best of your understanding.
End of Block: SURVEY INSTRUCTIONS
Start of Block: Helpfulness of DIL
Q1 Overall how helpful or unhelpful was DIL?

o Extremely helpful (1)
o Moderately helpful (2)
o Slightly helpful (3)
o Neither helpful nor unhelpful (4)
o Slightly unhelpful (5)
o Moderately unhelpful (6)
o Extremely unhelpful (7)

Q2 Was conversing with DIL easy?

o Extremely easy (1)
o Moderately easy (2)
o Slightly easy (3)
o Neither easy nor difficult (4)
o Slightly difficult (5)
o Moderately difficult (6)
o Extremely difficult (7)
Q3 Was the motivational messages useful?

o Extremely useful (1)
o Very useful (2)
o Moderately useful (3)
o Slightly useful (4)
o Not useful at all (5)

Q4 How helpful or unhelpful are the links to various published articles on relevant topics?

o Extremely helpful (1)
o Moderately helpful (2)
o Slightly helpful (3)
o Neither helpful nor unhelpful (4)
o Slightly unhelpful (5)
o Moderately unhelpful (6)
o Extremely unhelpful (7)
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Q5 Did DIL help you in improving your lifestyle and adherence to clinical guidelines?

o Extremely helpful (1)
o Moderately helpful (2)
o Slightly helpful (3)
o Neither helpful nor unhelpful (4)
o Slightly unhelpful (5)
o Moderately unhelpful (6)
o Extremely unhelpful (7)
End of Block: Helpfulness of DIL
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A P P E N D I X C - M I N N E S OTA L I V I N G W I T H H E A RT FA I LU R E
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APPENDIX D - IRB
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APPENDIX E - INFORMED CONSENT FORM

Informed Consent Form for
“DIL - A Conversational Agent for Congestive Heart Failure Patients ”
You are being asked to participate in a research project conducted by Sanjoy Moulik, a doctoral student in the Center
for Information Systems and Technology (CISAT), Claremont Graduate University (CGU). The research project will
be supervised by Dr. Samir Chatterjee, a distinguished faculty at CISAT, Claremont Graduate University. You are
being asked because of your willingness and non-coerced offer to volunteer for the study described below.
PURPOSE:
The purpose of this study is to evaluate and better understand the impact of technology especially
persuasive messages from an artificial intelligent bot on promoting behavior change for those who suffer from chronic
illnesses such as Congestive Heart Failure (CHF). A persuasive message is a communication between the bot and you
via Facebook Messenger Service on cell phones or other delivery method that includes information about your current
and past physical activity, recommendations on how you can improve your physical activity, diet and wellbeing factors
and motivational messages intended to encourage you to become more active in your life. Quantitative data such as
blood pressure, blood glucose, and weight will be collected via wireless home-monitoring devices and stored in a
secured cloud server. These measurements will form the basis of conversation between DIL and the participants. The
goal is to mine the data and provide suggestions for a healthier lifestyle, and to reduce hospital readmissions.
PARTICIPATION:
Your participation in this study is expected to take about two months of your time. A typical
conversation with DIL will take about 20 minutes, 1-2 times a week.
We will collect your blood pressure, weight, blood glucose data by using home-monitoring devices. By participating
in this study, you will be asked to take your blood pressure, blood glucose and weight reading at least once per week
using the provided devices. The blood pressure monitor will require you to simply place an arm cuff around your arm
and to press a “Start” button to take a blood pressure reading. The blood pressure device will automatically expand
the arm cuff, determine your blood pressure, and deflate the arm cuff once the measurement is done. Your weight
will be determined using a typical weight scale. Operating the scale is as simple as stepping on the scale to determine
your weight. Each device will be connected to your computer so that your information may be recorded. This
information is tracked to understand how your physical activity may or may not affect your blood pressure and weight.
The setup of the home-monitoring devices will take about 1 week and about 2-3 hours each day. This will include all
testing and making sure that everything is safely done. These devices will be placed discretely so to minimize any
unsightly looks in your house. No damage will be done to your home in placing the sensors. All devices will be
connected to your computer so that your weight, blood pressure, and blood glucose data may be recorded. If you feel
uncomfortable at any time during the study with having this type of information collected, you may request any or all
of the devices to be removed.
The information collected in this study will be used by our team to initiate a communication between DIL - an AI bot
and you via Facebook Messenger service a few times during the week. Included in the message will be motivational
information and suggestions of how you might improve your adherence to clinical and behavioral guidelines. You are
not required or obligated to follow any improvement suggestion. To communicate with the Bot, you will be asked to
use Facebook Messenger. If you do not know how to use a computer or a smartphone, we will provide training to
you. You will not be required to respond to any message.
You will be asked to complete a simple phone-based survey at the beginning and end of the study. This information
will be collected to help the research team to adjust the study for improvement or to better understand the impact of
the study on improving your adherence.
This study requires different types of technology to be used. All technology has been selected to be easy for you to
use. You will not be responsible for setting up the technology or for maintaining the technology. In the event that a
technical problem does occur, you are asked to contact Sanjoy Moulik at the IDEA Lab, Claremont Graduate
University, so that he may correct the problem within 24 hours. This may require him or a member of the team to
enter your home. We will contact you to setup a time that is convenient for you to have us enter your home.
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Once the study is completed, all technology used in the study will be removed and your home will be placed back to
its original condition, as prior to the start of the study. Lastly, at the end of the study, you will be given the option of
keeping a copy of all the data collected and any outcomes that may result from the study. The information collected
during the one-month study period will be used for research and development purposes, which you will be allowed to
read upon the completion of the document.
RISKS & BENEFITS:
Minimal risk exists in your participation in this study. All you are required to do is carry
on a conversation with DIL, and measure your weight, blood pressure, and blood glucose with the devices that are
provided to you.
As a participant, you are formally instructed that our system is not a real-time monitoring or emergency medical
system. It will be important to know that messages are automated and are not read by health care personnel.
Furthermore, a lack of response by our system to critical health information should be not construed as reassurance.
Hence you should always follow your normal course of action; in the event that you do not feel well, please get in
touch with your Care giver, and seek medical attention as soon as possible. The only difference among patients using
our system and those not using the system is the actual self-reporting of self-management practices not the practices
themselves.
The research in this study is expected to benefit the scientific community by increasing the understanding of how
computer technology can be used to improve adherence and promote better health.
The expected contribution of the study is to produce a novel artifact and demonstrate the efficacy and utility of the
tool to assist patients with heart failure in improving their self-care. If conversations with DIL can achieve better
adherence to clinical and behavioral guidelines, the patients will directly benefit from a better quality of life.
COMPENSATION:

You will receive $15 Starbucks gift card as a token compensation for your participation.

VOLUNTARY PARTICIPATION:
Please understand that your participation is completely voluntary. Your
decision whether or not to participate will in no way affect your current or future relationship with CGU or its faculty,
students, or staff. You have the right to withdraw from the research at any time without penalty. You also have the
right to refuse to answer any question(s) for any reason, without penalty.
CONFIDENTIALITY:
Your individual privacy will be maintained in all publications or presentations resulting
from this study. All data collected in the study will be maintained in a secure computer by the research team. No data
that can identify you by name or other identifiable marks will be shared during or after the study to the research
community (e.g., journal publications, conferences, etc.); confidentiality and anonymity of your information will be
strictly maintained, and all physical documents (e.g., completed survey forms) will be shredded upon the completion
of the study.
FURTHER INFORMATION:
If you have any questions or would like additional information about this research, please contact Sanjoy Moulik at:
Mailing Address
Sanjoy Moulik
IDEA LAB
130 East 9th St
Claremont, CA 91711

Phone Number
949-292-5127 (24 hours)

email Address
sanjoy.moulik@cgu.edu
Sanjoy.moulik@gmail.com

This study and its procedures have been approved by the Claremont Graduate University Institutional Review Board.
This Board is responsible for ensuring the protection of research participants. The CGU Institutional Review Board,
which is administered through the Office of Research and Sponsored Programs (ORSP), may be contacted at (909)
607-9406 with any questions.
A signed copy of this consent form will be given to you.
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